1
|
Ohlander J, Kromhout H, Vermeulen R, Portengen L, Kendzia B, Savary B, Cavallo D, Cattaneo A, Migliori E, Richiardi L, Plato N, Wichmann HE, Karrasch S, Consonni D, Landi MT, Caporaso NE, Siemiatycki J, Gustavsson P, Jöckel KH, Ahrens W, Pohlabeln H, Fernández-Tardón G, Zaridze D, Jolanta Lissowska JL, Beata Swiatkowska BS, John K Field JKF, McLaughlin JR, Demers PA, Pandics T, Forastiere F, Fabianova E, Schejbalova M, Foretova L, Janout V, Mates D, Barul C, Brüning T, Behrens T, Straif K, Schüz J, Olsson A, Peters S. Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationships. Scand J Work Environ Health 2024; 50:178-186. [PMID: 38264956 PMCID: PMC11064806 DOI: 10.5271/sjweh.4140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Indexed: 01/25/2024] Open
Abstract
OBJECTIVES The quantitative job-exposure matrix SYN-JEM consists of various dimensions: job-specific estimates, region-specific estimates, and prior expert ratings of jobs by the semi-quantitative DOM-JEM. We analyzed the effect of different JEM dimensions on the exposure-response relationships between occupational silica exposure and lung cancer risk to investigate how these variations influence estimates of exposure by a quantitative JEM and associated health endpoints. METHODS Using SYN-JEM, and alternative SYN-JEM specifications with varying dimensions included, cumulative silica exposure estimates were assigned to 16 901 lung cancer cases and 20 965 controls pooled from 14 international community-based case-control studies. Exposure-response relationships based on SYN-JEM and alternative SYN-JEM specifications were analyzed using regression analyses (by quartiles and log-transformed continuous silica exposure) and generalized additive models (GAM), adjusted for age, sex, study, cigarette pack-years, time since quitting smoking, and ever employment in occupations with established lung cancer risk. RESULTS SYN-JEM and alternative specifications generated overall elevated and similar lung cancer odds ratios ranging from 1.13 (1st quartile) to 1.50 (4th quartile). In the categorical and log-linear analyses SYN-JEM with all dimensions included yielded the best model fit, and exclusion of job-specific estimates from SYN-JEM yielded the poorest model fit. Additionally, GAM showed the poorest model fit when excluding job-specific estimates. CONCLUSION The established exposure-response relationship between occupational silica exposure and lung cancer was marginally influenced by varying the dimensions of SYN-JEM. Optimized modelling of exposure-response relationships will be obtained when incorporating all relevant dimensions, namely prior rating, job, time, and region. Quantitative job-specific estimates appeared to be the most prominent dimension for this general population JEM.
Collapse
Affiliation(s)
- Johan Ohlander
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Xu M, Ho V, Lavoué J, Olsson A, Schüz J, Richardson L, Parent ME, McLaughlin JR, Demers PA, Guénel P, Radoi L, Wichmann HE, Ahrens W, Jöckel KH, Consonni D, Landi MT, Richiardi L, Simonato L, 't' Mannetje A, Świątkowska B, Field JK, Pearce N, Siemiatycki J. Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studies. Am J Ind Med 2024; 67:200-213. [PMID: 38192156 DOI: 10.1002/ajim.23562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Revised: 11/19/2023] [Accepted: 12/22/2023] [Indexed: 01/10/2024]
Abstract
BACKGROUND Worldwide, lung cancer is the second leading cause of cancer death in women. The present study explored associations between occupational exposures that are prevalent among women, and lung cancer. METHODS Data from 10 case-control studies of lung cancer from Europe, Canada, and New Zealand conducted between 1988 and 2008 were combined. Lifetime occupational history and information on nonoccupational factors including smoking were available for 3040 incident lung cancer cases and 4187 controls. We linked each reported job to the Canadian Job-Exposure Matrix (CANJEM), which provided estimates of probability, intensity, and frequency of exposure to each selected agent in each job. For this analysis, we selected 15 agents (cleaning agents, biocides, cotton dust, synthetic fibers, formaldehyde, cooking fumes, organic solvents, cellulose, polycyclic aromatic hydrocarbons from petroleum, ammonia, metallic dust, alkanes C18+, iron compounds, isopropanol, and calcium carbonate) that had lifetime exposure prevalence of at least 5% in the combined study population. For each agent, we estimated lung cancer risk in each study center for ever-exposure, by duration of exposure, and by cumulative exposure, using separate logistic regression models adjusted for smoking and other covariates. We then estimated the meta-odds ratios using random-effects meta-analysis. RESULTS AND CONCLUSIONS None of the agents assessed showed consistent and compelling associations with lung cancer among women. The following agents showed elevated odds ratio in some analyses: metallic dust, iron compounds, isopropanol, and organic solvents. Future research into occupational lung cancer risk factors among women should prioritize these agents.
Collapse
Affiliation(s)
- Mengting Xu
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| | - Vikki Ho
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| | - Jérôme Lavoué
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| | - Ann Olsson
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Lesley Richardson
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| | - Marie-Elise Parent
- Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada
| | - John R McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Paul A Demers
- Occupational Cancer Research Centre, Ontario Health, Toronto, Canada
| | - Pascal Guénel
- Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, U1018 Inserm, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France
| | - Loredana Radoi
- Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, U1018 Inserm, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | | | - Lorenzo Richiardi
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Lorenzo Simonato
- Department of Cardiovascular Sciences and Public Health, University of Padova, Padova, Italy
| | - Andrea 't' Mannetje
- Research Centre for Hauora and Health, Massey University, Wellington, New Zealand
| | | | - John K Field
- Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, Liverpool, UK
| | - Neil Pearce
- Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
| | - Jack Siemiatycki
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| |
Collapse
|
3
|
Wan W, Peters S, Portengen L, Olsson A, Schüz J, Ahrens W, Schejbalova M, Boffetta P, Behrens T, Brüning T, Kendzia B, Consonni D, Demers PA, Fabiánová E, Fernández-Tardón G, Field JK, Forastiere F, Foretova L, Guénel P, Gustavsson P, Jöckel KH, Karrasch S, Landi MT, Lissowska J, Barul C, Mates D, McLaughlin JR, Merletti F, Migliore E, Richiardi L, Pándics T, Pohlabeln H, Siemiatycki J, Świątkowska B, Wichmann HE, Zaridze D, Ge C, Straif K, Kromhout H, Vermeulen R. Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies. Am J Respir Crit Care Med 2024; 209:185-196. [PMID: 37812782 PMCID: PMC10806413 DOI: 10.1164/rccm.202306-0942oc] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Accepted: 10/06/2023] [Indexed: 10/11/2023] Open
Abstract
Rationale: Benzene has been classified as carcinogenic to humans, but there is limited evidence linking benzene exposure to lung cancer. Objectives: We aimed to examine the relationship between occupational benzene exposure and lung cancer. Methods: Subjects from 14 case-control studies across Europe and Canada were pooled. We used a quantitative job-exposure matrix to estimate benzene exposure. Logistic regression models assessed lung cancer risk across different exposure indices. We adjusted for smoking and five main occupational lung carcinogens and stratified analyses by smoking status and lung cancer subtypes. Measurements and Main Results: Analyses included 28,048 subjects (12,329 cases, 15,719 control subjects). Lung cancer odds ratios ranged from 1.12 (95% confidence interval, 1.03-1.22) to 1.32 (95% confidence interval, 1.18-1.48) (Ptrend = 0.002) for groups with the lowest and highest cumulative occupational exposures, respectively, compared with unexposed subjects. We observed an increasing trend of lung cancer with longer duration of exposure (Ptrend < 0.001) and a decreasing trend with longer time since last exposure (Ptrend = 0.02). These effects were seen for all lung cancer subtypes, regardless of smoking status, and were not influenced by specific occupational groups, exposures, or studies. Conclusions: We found consistent and robust associations between different dimensions of occupational benzene exposure and lung cancer after adjusting for smoking and main occupational lung carcinogens. These associations were observed across different subgroups, including nonsmokers. Our findings support the hypothesis that occupational benzene exposure increases the risk of developing lung cancer. Consequently, there is a need to revisit published epidemiological and molecular data on the pulmonary carcinogenicity of benzene.
Collapse
Affiliation(s)
- Wenxin Wan
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Lützen Portengen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Ann Olsson
- International Agency for Research on Cancer/World Health Organization, Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer/World Health Organization, Lyon, France
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
- Faculty of Mathematics and Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany
| | - Miriam Schejbalova
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czechia
| | - Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany
| | - Dario Consonni
- Epidemiology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Paul A. Demers
- Occupational Cancer Research Centre, Ontario Health, Toronto, Ontario, Canada
| | - Eleonóra Fabiánová
- Regional Authority of Public Health, Banská Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Guillermo Fernández-Tardón
- Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain
- Health Research Institute of Asturias, University Institute of Oncology of Asturias – Cajastur Social Program, University of Oviedo, Oviedo, Spain
| | - John K. Field
- Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
| | | | | | - Pascal Guénel
- Center for Research in Epidemiology and Population Health, Team Exposome and Heredity, U1018 Institut national de la santé et de la recherche médicale, University of Paris-Saclay, Villejuif, France
| | - Per Gustavsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
| | - Stefan Karrasch
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, and
- Comprehensive Pneumology Center Munich, Member of the German Center for Lung Research, Munich, Germany
- Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany
| | - Maria Teresa Landi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - Jolanta Lissowska
- Epidemiology Unit, Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Christine Barul
- Université Rennes, Institut national de la santé et de la recherche médicale, École des hautes études en santé publique, Institut de recherche en santé, environnement et travail, UMR_S 1085, Pointe-à-Pitre, France
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | - John R. McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Enrica Migliore
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | | | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
| | - Jack Siemiatycki
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada
| | - Beata Świątkowska
- Department of Environmental Epidemiology, The Nofer Institute of Occupational Medicine, Lodz, Poland
| | - Heinz-Erich Wichmann
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany
- Comprehensive Pneumology Center Munich, Member of the German Center for Lung Research, Munich, Germany
| | - David Zaridze
- Department of Cancer Epidemiology and Prevention, N.N. Blokhin National Research Center of Oncology, Moscow, Russia
| | - Calvin Ge
- Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek, Utrecht, the Netherlands
| | - Kurt Straif
- ISGlobal, Barcelona, Spain; and
- Boston College, Boston, Massachusetts
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| |
Collapse
|
4
|
Olsson A, Bouaoun L, Schüz J, Vermeulen R, Behrens T, Ge C, Kromhout H, Siemiatycki J, Gustavsson P, Boffetta P, Kendzia B, Radoi L, Barul C, Karrasch S, Wichmann HE, Consonni D, Landi MT, Caporaso NE, Merletti F, Migliore E, Richiardi L, Jöckel KH, Ahrens W, Pohlabeln H, Fernández-Tardón G, Zaridze D, Field JK, Lissowska J, Świątkowska B, McLaughlin JR, Demers PA, Schejbalova M, Foretova L, Janout V, Pándics T, Fabianova E, Mates D, Forastiere F, Straif K, Brüning T, Vlaanderen J, Peters S. Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). Environ Health Perspect 2024; 132:17005. [PMID: 38236172 PMCID: PMC10795675 DOI: 10.1289/ehp13380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 12/11/2023] [Accepted: 12/20/2023] [Indexed: 01/19/2024]
Abstract
BACKGROUND While much research has been done to identify individual workplace lung carcinogens, little is known about joint effects on risk when workers are exposed to multiple agents. OBJECTIVES We investigated the pairwise joint effects of occupational exposures to asbestos, respirable crystalline silica, metals (i.e., nickel, chromium-VI), and polycyclic aromatic hydrocarbons (PAH) on lung cancer risk, overall and by major histologic subtype, while accounting for cigarette smoking. METHODS In the international 14-center SYNERGY project, occupational exposures were assigned to 16,901 lung cancer cases and 20,965 control subjects using a quantitative job-exposure matrix (SYN-JEM). Odds ratios (ORs) and 95% confidence intervals (CIs) were computed for ever vs. never exposure using logistic regression models stratified by sex and adjusted for study center, age, and smoking habits. Joint effects among pairs of agents were assessed on multiplicative and additive scales, the latter by calculating the relative excess risk due to interaction (RERI). RESULTS All pairwise joint effects of lung carcinogens in men were associated with an increased risk of lung cancer. However, asbestos/metals and metals/PAH resulted in less than additive effects; while the chromium-VI/silica pair showed marginally synergistic effect in relation to adenocarcinoma (RERI: 0.24; CI: 0.02, 0.46; p = 0.05). In women, several pairwise joint effects were observed for small cell lung cancer including exposure to PAH/silica (OR = 5.12; CI: 1.77, 8.48), and to asbestos/silica (OR = 4.32; CI: 1.35, 7.29), where exposure to PAH/silica resulted in a synergistic effect (RERI: 3.45; CI: 0.10, 6.8). DISCUSSION Small or no deviation from additive or multiplicative effects was observed, but co-exposure to the selected lung carcinogens resulted generally in higher risk than exposure to individual agents, highlighting the importance to reduce and control exposure to carcinogens in workplaces and the general environment. https://doi.org/10.1289/EHP13380.
Collapse
Affiliation(s)
- Ann Olsson
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Liacine Bouaoun
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Calvin Ge
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Jack Siemiatycki
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada
| | - Per Gustavsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Loredana Radoi
- Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, U1018 Inserm, University Paris-Saclay, University Paris Cité, Villejuif, France
| | - Christine Barul
- University Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) -UMR_S 1085, Pointe-à-Pitre, France
| | - Stefan Karrasch
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany
- Institute of Epidemiology, Helmholtz Zentrum München—German Research Center for Environmental Health, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München—German Research Center for Environmental Health, Neuherberg, Germany
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig Maximilians University, Munich, Germany
| | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Maria Teresa Landi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA
| | - Neil E. Caporaso
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Enrica Migliore
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, Essen, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
- Faculty of Mathematics and Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
| | | | - David Zaridze
- Department of Cancer Epidemiology and Prevention, N.N. Blokhin National Research Centre of Oncology, Moscow, Russia
| | - John K. Field
- Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
| | - Jolanta Lissowska
- Epidemiology Unit, Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Beata Świątkowska
- Department of Environmental Epidemiology, The Nofer Institute of Occupational Medicine, Lodz, Poland
| | - John R. McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Paul A. Demers
- Occupational Cancer Research Centre, Ontario Health, Toronto, Canada
| | - Miriam Schejbalova
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Vladimir Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
| | | | - Eleonora Fabianova
- Regional Authority of Public Health, Banská Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | | | - Kurt Straif
- ISGlobal, Barcelona, Spain
- Boston College, Chestnut Hill, Massachusetts, USA
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| |
Collapse
|
5
|
Behrens T, Ge C, Vermeulen R, Kendzia B, Olsson A, Schüz J, Kromhout H, Pesch B, Peters S, Portengen L, Gustavsson P, Mirabelli D, Guénel P, Luce D, Consonni D, Caporaso NE, Landi MT, Field JK, Karrasch S, Wichmann HE, Siemiatycki J, Parent ME, Richiardi L, Simonato L, Jöckel KH, Ahrens W, Pohlabeln H, Fernández-Tardón G, Zaridze D, McLaughlin JR, Demers PA, Świątkowska B, Lissowska J, Pándics T, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Boffetta P, Bueno-de-Mesquita B, Forastiere F, Straif K, Brüning T. Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY). Int J Cancer 2023; 152:645-660. [PMID: 36054442 DOI: 10.1002/ijc.34272] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 07/11/2022] [Accepted: 07/14/2022] [Indexed: 02/01/2023]
Abstract
There is limited evidence regarding the exposure-effect relationship between lung-cancer risk and hexavalent chromium (Cr(VI)) or nickel. We estimated lung-cancer risks in relation to quantitative indices of occupational exposure to Cr(VI) and nickel and their interaction with smoking habits. We pooled 14 case-control studies from Europe and Canada, including 16 901 lung-cancer cases and 20 965 control subjects. A measurement-based job-exposure-matrix estimated job-year-region specific exposure levels to Cr(VI) and nickel, which were linked to the subjects' occupational histories. Odds ratios (OR) and associated 95% confidence intervals (CI) were calculated by unconditional logistic regression, adjusting for study, age group, smoking habits and exposure to other occupational lung carcinogens. Due to their high correlation, we refrained from mutually adjusting for Cr(VI) and nickel independently. In men, ORs for the highest quartile of cumulative exposure to CR(VI) were 1.32 (95% CI 1.19-1.47) and 1.29 (95% CI 1.15-1.45) in relation to nickel. Analogous results among women were: 1.04 (95% CI 0.48-2.24) and 1.29 (95% CI 0.60-2.86), respectively. In men, excess lung-cancer risks due to occupational Cr(VI) and nickel exposure were also observed in each stratum of never, former and current smokers. Joint effects of Cr(VI) and nickel with smoking were in general greater than additive, but not different from multiplicative. In summary, relatively low cumulative levels of occupational exposure to Cr(VI) and nickel were associated with increased ORs for lung cancer, particularly in men. However, we cannot rule out a combined classical measurement and Berkson-type of error structure, which may cause differential bias of risk estimates.
Collapse
Affiliation(s)
- Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-University Bochum (IPA), Germany
| | - Calvin Ge
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-University Bochum (IPA), Germany
| | - Ann Olsson
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Beate Pesch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-University Bochum (IPA), Germany
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Lützen Portengen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Per Gustavsson
- The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Dario Mirabelli
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Pascal Guénel
- Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, U1018 Inserm, University Paris-Saclay, Institut Gustave Roussy, Villejuif, France
| | - Danièle Luce
- Univ. Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Pointe-à-Pitre, France
| | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | | | | | - John K Field
- Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, Liverpool, UK
| | - Stefan Karrasch
- Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital LMU Munich; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
| | - Jack Siemiatycki
- University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
| | - Marie-Elise Parent
- Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, Quebec, Canada
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Simonato
- Department of Cardiovascular Sciences and Public Health, University of Padova, Padova, Italy
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany
| | | | - David Zaridze
- Department of Epidemiology and Prevention, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia
| | - John R McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Paul A Demers
- Occupational Cancer Research Centre, Ontario Health, Toronto, Canada
| | | | - Jolanta Lissowska
- Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | | | | | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Vladimír Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
| | - Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Bas Bueno-de-Mesquita
- Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Francesco Forastiere
- Environmental Research Group, School of Public Health, Imperial College, London, UK, and National Research Council (CNR-Irib), Palermo, Italy
| | - Kurt Straif
- ISGlobal, Barcelona, Spain
- Boston College, Chestnut Hill, Massachusetts, USA
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-University Bochum (IPA), Germany
| |
Collapse
|
6
|
Wang Z, Emmerich A, Pillon NJ, Moore T, Hemerich D, Cornelis MC, Mazzaferro E, Broos S, Ahluwalia TS, Bartz TM, Bentley AR, Bielak LF, Chong M, Chu AY, Berry D, Dorajoo R, Dueker ND, Kasbohm E, Feenstra B, Feitosa MF, Gieger C, Graff M, Hall LM, Haller T, Hartwig FP, Hillis DA, Huikari V, Heard-Costa N, Holzapfel C, Jackson AU, Johansson Å, Jørgensen AM, Kaakinen MA, Karlsson R, Kerr KF, Kim B, Koolhaas CM, Kutalik Z, Lagou V, Lind PA, Lorentzon M, Lyytikäinen LP, Mangino M, Metzendorf C, Monroe KR, Pacolet A, Pérusse L, Pool R, Richmond RC, Rivera NV, Robiou-du-Pont S, Schraut KE, Schulz CA, Stringham HM, Tanaka T, Teumer A, Turman C, van der Most PJ, Vanmunster M, van Rooij FJA, van Vliet-Ostaptchouk JV, Zhang X, Zhao JH, Zhao W, Balkhiyarova Z, Balslev-Harder MN, Baumeister SE, Beilby J, Blangero J, Boomsma DI, Brage S, Braund PS, Brody JA, Bruinenberg M, Ekelund U, Liu CT, Cole JW, Collins FS, Cupples LA, Esko T, Enroth S, Faul JD, Fernandez-Rhodes L, Fohner AE, Franco OH, Galesloot TE, Gordon SD, Grarup N, Hartman CA, Heiss G, Hui J, Illig T, Jago R, James A, Joshi PK, Jung T, Kähönen M, Kilpeläinen TO, Koh WP, Kolcic I, Kraft PP, Kuusisto J, Launer LJ, Li A, Linneberg A, Luan J, Vidal PM, Medland SE, Milaneschi Y, Moscati A, Musk B, Nelson CP, Nolte IM, Pedersen NL, Peters A, Peyser PA, Power C, Raitakari OT, Reedik M, Reiner AP, Ridker PM, Rudan I, Ryan K, Sarzynski MA, Scott LJ, Scott RA, Sidney S, Siggeirsdottir K, Smith AV, Smith JA, Sonestedt E, Strøm M, Tai ES, Teo KK, Thorand B, Tönjes A, Tremblay A, Uitterlinden AG, Vangipurapu J, van Schoor N, Völker U, Willemsen G, Williams K, Wong Q, Xu H, Young KL, Yuan JM, Zillikens MC, Zonderman AB, Ameur A, Bandinelli S, Bis JC, Boehnke M, Bouchard C, Chasman DI, Smith GD, de Geus EJC, Deldicque L, Dörr M, Evans MK, Ferrucci L, Fornage M, Fox C, Garland T, Gudnason V, Gyllensten U, Hansen T, Hayward C, Horta BL, Hyppönen E, Jarvelin MR, Johnson WC, Kardia SLR, Kiemeney LA, Laakso M, Langenberg C, Lehtimäki T, Marchand LL, Magnusson PKE, Martin NG, Melbye M, Metspalu A, Meyre D, North KE, Ohlsson C, Oldehinkel AJ, Orho-Melander M, Pare G, Park T, Pedersen O, Penninx BWJH, Pers TH, Polasek O, Prokopenko I, Rotimi CN, Samani NJ, Sim X, Snieder H, Sørensen TIA, Spector TD, Timpson NJ, van Dam RM, van der Velde N, van Duijn CM, Vollenweider P, Völzke H, Voortman T, Waeber G, Wareham NJ, Weir DR, Wichmann HE, Wilson JF, Hevener AL, Krook A, Zierath JR, Thomis MAI, Loos RJF, Hoed MD. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention. Nat Genet 2022; 54:1332-1344. [PMID: 36071172 PMCID: PMC9470530 DOI: 10.1038/s41588-022-01165-1] [Citation(s) in RCA: 54] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Accepted: 07/18/2022] [Indexed: 02/02/2023]
Abstract
Although physical activity and sedentary behavior are moderately heritable, little is known about the mechanisms that influence these traits. Combining data for up to 703,901 individuals from 51 studies in a multi-ancestry meta-analysis of genome-wide association studies yields 99 loci that associate with self-reported moderate-to-vigorous intensity physical activity during leisure time (MVPA), leisure screen time (LST) and/or sedentary behavior at work. Loci associated with LST are enriched for genes whose expression in skeletal muscle is altered by resistance training. A missense variant in ACTN3 makes the alpha-actinin-3 filaments more flexible, resulting in lower maximal force in isolated type IIA muscle fibers, and possibly protection from exercise-induced muscle damage. Finally, Mendelian randomization analyses show that beneficial effects of lower LST and higher MVPA on several risk factors and diseases are mediated or confounded by body mass index (BMI). Our results provide insights into physical activity mechanisms and its role in disease prevention.
Collapse
Affiliation(s)
- Zhe Wang
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - Andrew Emmerich
- Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden
| | - Nicolas J Pillon
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Tim Moore
- Division of Cardiology, Department of Medicine, University of California, Los Angeles, CA, USA
| | - Daiane Hemerich
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Marilyn C Cornelis
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Eugenia Mazzaferro
- The Beijer Laboratory and Department of Immunology, Genetics and Pathology, Uppsala University and SciLifeLab, Uppsala, Sweden
| | - Siacia Broos
- Faculty of Movement and Rehabilitation Sciences, Department of Movement Sciences - Exercise Physiology Research Group, KU Leuven, Leuven, Belgium
- Faculty of Movement and Rehabilitation Sciences, Department of Movement Sciences - Physical Activity, Sports & Health Research Group, KU Leuven, Leuven, Belgium
| | - Tarunveer S Ahluwalia
- Steno Diabetes Center Copenhagen, Herlev, Denmark
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- The Bioinformatics Center, Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | - Traci M Bartz
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Amy R Bentley
- Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Lawrence F Bielak
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Mike Chong
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Audrey Y Chu
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA
- GlaxoSmithKline, Cambridge, MA, USA
| | - Diane Berry
- Division of Population, Policy and Practice, Great Ormond Street Hospital Institute for Child Health, University College London, London, UK
| | - Rajkumar Dorajoo
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
- Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore
| | - Nicole D Dueker
- John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL, USA
- Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Elisa Kasbohm
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
- Institute of Mathematics and Computer Science, University of Greifswald, Greifswald, Germany
| | - Bjarke Feenstra
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
| | - Mary F Feitosa
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany
| | - Mariaelisa Graff
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
| | - Leanne M Hall
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK
| | - Toomas Haller
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Fernando P Hartwig
- Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
- MRC Integrative Epidemiology Unit, NIHR Bristol Biomedical Research Center, University of Bristol, Bristol, UK
| | - David A Hillis
- Genetics, Genomics, and Bioinformatics Graduate Program, University of California, Riverside, CA, USA
| | - Ville Huikari
- Institute of Health Sciences, University of Oulu, Oulu, Finland
| | - Nancy Heard-Costa
- Framingham Heart Study, Framingham, MA, USA
- Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Christina Holzapfel
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany
- Institute for Nutritional Medicine, School of Medicine, Technical University of Munich, Munich, Germany
| | - Anne U Jackson
- Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
| | - Åsa Johansson
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Anja Moltke Jørgensen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Marika A Kaakinen
- Section of Statistical Multi-omics, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
| | - Robert Karlsson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Kathleen F Kerr
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Boram Kim
- Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, South Korea
| | - Chantal M Koolhaas
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - Zoltan Kutalik
- University Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
- Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
| | | | - Penelope A Lind
- Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Biomedical Science, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - Mattias Lorentzon
- Geriatric Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital Mölndal, Gothenburg, Sweden
- Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland
- Finnish Cardiovascular Research Center - Tampere, Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK
- NIHR Biomedical Research Centre at Guy's and St Thomas' Foundation Trust, London, UK
| | - Christoph Metzendorf
- The Beijer Laboratory and Department of Immunology, Genetics and Pathology, Uppsala University and SciLifeLab, Uppsala, Sweden
| | - Kristine R Monroe
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Alexander Pacolet
- Faculty of Movement and Rehabilitation Sciences, Department of Movement Sciences - Exercise Physiology Research Group, KU Leuven, Leuven, Belgium
| | - Louis Pérusse
- Department of Kinesiology, Université Laval, Quebec, Quebec, Canada
- Centre Nutrition Santé et Société (NUTRISS), Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada
| | - Rene Pool
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands
| | - Rebecca C Richmond
- MRC Integrative Epidemiology Unit and Avon Longitudinal Study of Parents and Children, University of Bristol Medical School, Population Health Sciences and Avon Longitudinal Study of Parents and Children, University of Bristol, Bristol, UK
| | - Natalia V Rivera
- Respiratory Division, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Rheumatology Division, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Center of Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden
| | - Sebastien Robiou-du-Pont
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Katharina E Schraut
- Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK
| | - Christina-Alexandra Schulz
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
- Department of Nutrition and Food Sciences, Nutritional Epidemiology, University of Bonn, Bonn, Germany
| | - Heather M Stringham
- Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
| | - Toshiko Tanaka
- Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
| | - Constance Turman
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Peter J van der Most
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Mathias Vanmunster
- Faculty of Movement and Rehabilitation Sciences, Department of Movement Sciences - Exercise Physiology Research Group, KU Leuven, Leuven, Belgium
| | - Frank J A van Rooij
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - Jana V van Vliet-Ostaptchouk
- Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Xiaoshuai Zhang
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
- School of Public Health, Department of Biostatistics, Shandong University, Jinan, China
| | - Jing-Hua Zhao
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Zhanna Balkhiyarova
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
- Department of Clinical and Experimental Medicine, University of Surrey, Guilford, UK
- People-Centred Artificial Intelligence Institute, University of Surrey, Guilford, UK
| | - Marie N Balslev-Harder
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Sebastian E Baumeister
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
- University of Münster, Münster, Germany
| | - John Beilby
- Diagnostic Genomics, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Brownsville, TX, USA
| | - Dorret I Boomsma
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands
| | - Soren Brage
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - Peter S Braund
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK
| | - Jennifer A Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
| | | | - Ulf Ekelund
- Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway
- Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
| | - Ching-Ti Liu
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - John W Cole
- Vascular Neurology, Department of Neurology, University of Maryland School of Medicine and the Baltimore VAMC, Baltimore, MD, USA
| | - Francis S Collins
- Center for Precision Health Research, National Human Genome Research Institute, NIH, Bethesda, MD, USA
| | - L Adrienne Cupples
- Framingham Heart Study, Framingham, MA, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Tõnu Esko
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Stefan Enroth
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA
| | - Lindsay Fernandez-Rhodes
- Department of Biobehavioral Health, College of Health and Human Development, Pennsylvania State University, University Park, PA, USA
| | - Alison E Fohner
- Department of Epidemiology, Institute of Public Health Genetics, Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA
| | - Oscar H Franco
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
- Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
| | - Tessel E Galesloot
- Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Scott D Gordon
- Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Niels Grarup
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Catharina A Hartman
- Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Gerardo Heiss
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
| | - Jennie Hui
- Diagnostic Genomics, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
- School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia
- Busselton Population Medical Research Institute, Busselton, Western Australia, Australia
| | - Thomas Illig
- Hannover Unified Biobank, Hannover Medical School, Hannover, Germany
- Department of Human Genetics, Hannover Medical School, Hannover, Germany
| | - Russell Jago
- Centre for Exercise Nutrition & Health Sciences, School for Policy Studies, University of Bristol, Bristol, UK
| | - Alan James
- Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Western Australia, Perth, Australia
| | - Peter K Joshi
- Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK
- Humanity Inc, Boston, MA, USA
| | - Taeyeong Jung
- Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, South Korea
| | - Mika Kähönen
- Finnish Cardiovascular Research Center - Tampere, Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
- Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
| | - Tuomas O Kilpeläinen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Woon-Puay Koh
- Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Singapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore
| | - Ivana Kolcic
- Department of Public Health, University of Split School of Medicine, Split, Croatia
| | - Peter P Kraft
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Johanna Kuusisto
- Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
| | - Lenore J Launer
- Laboratory of Epidemiology and Population Sciences, National Institutes of Health, Baltimore, MD, USA
| | - Aihua Li
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Allan Linneberg
- Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Jian'an Luan
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - Pedro Marques Vidal
- Division of Internal Medicine, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - Sarah E Medland
- Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Psychology and Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia
| | - Yuri Milaneschi
- Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
| | - Arden Moscati
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Bill Musk
- Busselton Population Medical Research Institute, Busselton, Western Australia, Australia
| | - Christopher P Nelson
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK
| | - Ilja M Nolte
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Nancy L Pedersen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Annette Peters
- Institute of Epidemiology, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany
| | - Patricia A Peyser
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Christine Power
- Division of Population, Policy and Practice, Great Ormond Street Hospital Institute for Child Health, University College London, London, UK
| | - Olli T Raitakari
- Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
- Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland
| | - Mägi Reedik
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Alex P Reiner
- Department of Epidemiology, University of Washington, Seattle, WA, USA
| | - Paul M Ridker
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Igor Rudan
- Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK
| | - Kathy Ryan
- Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Mark A Sarzynski
- Department of Exercise Science, University of South Carolina, Columbia, SC, USA
| | - Laura J Scott
- Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
| | - Robert A Scott
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - Stephen Sidney
- Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
| | | | - Albert V Smith
- Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
- Icelandic Heart Association, Kópavogur, Iceland
| | - Jennifer A Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA
| | - Emily Sonestedt
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
| | - Marin Strøm
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
- Faculty of Health Sciences, University of the Faroe Islands, Tórshavn, Faroe Islands
| | - E Shyong Tai
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
- Duke-NUS Medical School, Singapore, Singapore
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Koon K Teo
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Barbara Thorand
- Institute of Epidemiology, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany
| | - Anke Tönjes
- Department of Medicine, University of Leipzig, Leipzig, Germany
| | - Angelo Tremblay
- Department of Kinesiology, Université Laval, Quebec, Quebec, Canada
- Centre Nutrition Santé et Société (NUTRISS), Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada
| | - Andre G Uitterlinden
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Jagadish Vangipurapu
- Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
| | - Natasja van Schoor
- Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands
| | - Uwe Völker
- German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
| | - Gonneke Willemsen
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands
| | - Kayleen Williams
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Quenna Wong
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Huichun Xu
- Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Kristin L Young
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
| | - Jian Min Yuan
- Division of Cancer Control and Population Sciences, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
| | - M Carola Zillikens
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Alan B Zonderman
- Laboratory of Epidemiology and Population Science, National Instiute on Aging, National Institutes of Health, Bethesda, MD, USA
| | - Adam Ameur
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | | | - Joshua C Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
| | - Michael Boehnke
- Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
| | - Claude Bouchard
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA
| | - Daniel I Chasman
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - George Davey Smith
- MRC Integrative Epidemiology Unit, NIHR Bristol Biomedical Research Center, University of Bristol, Bristol, UK
- Population Health Science, Bristol Medical School, NIHR Bristol Biomedical Research Center, University of Bristol, Bristol, UK
| | - Eco J C de Geus
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands
| | - Louise Deldicque
- Faculty of Movement and Rehabilitation Sciences, Institute of Neuroscience, UC Louvain, Louvain-la-Neuve, Belgium
| | - Marcus Dörr
- German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
- Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany
| | - Michele K Evans
- Laboratory of Epidemiology and Population Science, National Instiute on Aging, National Institutes of Health, Bethesda, MD, USA
| | - Luigi Ferrucci
- Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA
| | - Myriam Fornage
- Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Caroline Fox
- Genetics and Pharmacogenomics (GpGx), Merck Research Labs, Boston, MA, USA
| | - Theodore Garland
- Department of Evolution, Ecology, and Organismal Biology, University of California, Riverside, Riverside, CA, USA
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kópavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Ulf Gyllensten
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Torben Hansen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
| | - Bernardo L Horta
- Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
| | - Elina Hyppönen
- Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
- South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
- Population, Policy and Practice, Great Ormond Street Hospital Institute for Child Health, University College London, London, UK
| | - Marjo-Riitta Jarvelin
- Institute of Health Sciences, University of Oulu, Oulu, Finland
- Department of Epidemiology and Biostatistics and HPA-MRC Center, School of Public Health, Imperial College London, London, UK
| | - W Craig Johnson
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Sharon L R Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Lambertus A Kiemeney
- Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Markku Laakso
- Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
| | - Claudia Langenberg
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
- Computational Medicine, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland
- Finnish Cardiovascular Research Center - Tampere, Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Loic Le Marchand
- Epidemiology Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Nicholas G Martin
- Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Mads Melbye
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- K.G.Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
- Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
- Center for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Andres Metspalu
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - David Meyre
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Kari E North
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
| | - Claes Ohlsson
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Department of Drug Treatment, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Albertine J Oldehinkel
- Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | | | - Guillaume Pare
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Taesung Park
- Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, South Korea
- Department of Statistics, Seoul National University, Seoul, South Korea
| | - Oluf Pedersen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Brenda W J H Penninx
- Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
| | - Tune H Pers
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Ozren Polasek
- University of Split School of Medicine, Split, Croatia
| | - Inga Prokopenko
- Department of Clinical and Experimental Medicine, University of Surrey, Guilford, UK
- People-Centred Artificial Intelligence Institute, University of Surrey, Guilford, UK
- UMR 8199 - EGID, Institut Pasteur de Lille, CNRS, University of Lille, Lille, France
| | - Charles N Rotimi
- Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Nilesh J Samani
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK
| | - Xueling Sim
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
| | - Harold Snieder
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Thorkild I A Sørensen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Department of Public Health, Section of Epidemiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK
| | - Nicholas J Timpson
- MRC Integrative Epidemiology Unit, University of Bristol Medical School, University of Bristol, Bristol, UK
| | - Rob M van Dam
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
- Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, USA
| | - Nathalie van der Velde
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
- Section of Geriatrics, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
- Amsterdam Public Health, Aging and Later Life, Amsterdam, the Netherlands
| | - Cornelia M van Duijn
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
- Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - Peter Vollenweider
- Division of Internal Medicine, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
| | - Trudy Voortman
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - Gérard Waeber
- Division of Internal Medicine, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | | | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany
| | - James F Wilson
- Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK
- MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
| | - Andrea L Hevener
- Division of Endocrinology, Department of Medicine, University of California, Los Angeles, CA, USA
| | - Anna Krook
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Juleen R Zierath
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
| | - Martine A I Thomis
- Faculty of Movement and Rehabilitation Sciences, Department of Movement Sciences - Physical Activity, Sports & Health Research Group, KU Leuven, Leuven, Belgium
| | - Ruth J F Loos
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Marcel den Hoed
- The Beijer Laboratory and Department of Immunology, Genetics and Pathology, Uppsala University and SciLifeLab, Uppsala, Sweden.
| |
Collapse
|
7
|
Olsson A, Guha N, Bouaoun L, Kromhout H, Peters S, Siemiatycki J, Ho V, Gustavsson P, Boffetta P, Vermeulen R, Behrens T, Brüning T, Kendzia B, Guénel P, Luce D, Karrasch S, Wichmann HE, Consonni D, Landi MT, Caporaso NE, Merletti F, Mirabelli D, Richiardi L, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Field JK, Lissowska J, Świątkowska B, McLaughlin JR, Demers PA, Bencko V, Foretova L, Janout V, Pándics T, Fabianova E, Mates D, Forastiere F, Bueno-de-Mesquita B, Schüz J, Straif K. Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). Cancer Epidemiol Biomarkers Prev 2022; 31:1433-1441. [PMID: 35437574 PMCID: PMC9377765 DOI: 10.1158/1055-9965.epi-21-1428] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 03/22/2022] [Accepted: 04/11/2022] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Exposure to polycyclic aromatic hydrocarbons (PAH) occurs widely in occupational settings. We investigated the association between occupational exposure to PAH and lung cancer risk and joint effects with smoking within the SYNERGY project. METHODS We pooled 14 case-control studies with information on lifetime occupational and smoking histories conducted between 1985 and 2010 in Europe and Canada. Exposure to benzo[a]pyrene (BaP) was used as a proxy of PAH and estimated from a quantitative general population job-exposure matrix. Multivariable unconditional logistic regression models, adjusted for smoking and exposure to other occupational lung carcinogens, estimated ORs, and 95% confidence intervals (CI). RESULTS We included 16,901 lung cancer cases and 20,965 frequency-matched controls. Adjusted OR for PAH exposure (ever) was 1.08 (CI, 1.02-1.15) in men and 1.20 (CI, 1.04-1.38) in women. When stratified by smoking status and histologic subtype, the OR for cumulative exposure ≥0.24 BaP μg/m3-years in men was higher in never smokers overall [1.31 (CI, 0.98-1.75)], for small cell [2.53 (CI, 1.28-4.99)] and squamous cell cancers [1.33 (CI, 0.80-2.21)]. Joint effects between PAH and smoking were observed. Restricting analysis to the most recent studies showed no increased risk. CONCLUSIONS Elevated lung cancer risk associated with PAH exposure was observed in both sexes, particularly for small cell and squamous cell cancers, after accounting for cigarette smoking and exposure to other occupational lung carcinogens. IMPACT The lack of association between PAH and lung cancer in more recent studies merits further research under today's exposure conditions and worker protection measures.
Collapse
Affiliation(s)
- Ann Olsson
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Neela Guha
- Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, California
| | - Liacine Bouaoun
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Jack Siemiatycki
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada
| | - Vikki Ho
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada
| | - Per Gustavsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Pascal Guénel
- Center for research in Epidemiology and Population Health (CESP), Exposome and Heredity team, Inserm U1018, University Paris-Saclay, Villejuif, France
| | - Danièle Luce
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France
| | - Stefan Karrasch
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
- Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig Maximilians University, Munich, Germany
| | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Maria Teresa Landi
- Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland
| | - Neil E Caporaso
- Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Dario Mirabelli
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, Essen, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
- Faculty of Mathematics and Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
| | - Adonina Tardón
- Department of Public Health, University of Oviedo. ISPA and CIBERESP, Oviedo, Spain
| | - David Zaridze
- Department of cancer epidemiology and Prevention, N.N. Blokhin National Research Centre of oncology, Moscow, Russia
| | - John K Field
- Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
| | - Jolanta Lissowska
- Epidemiology Unit, Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Beata Świątkowska
- Department of Environmental Epidemiology, The Nofer Institute of Occupational Medicine, Lodz, Poland
| | - John R McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Paul A Demers
- Occupational Cancer Research Centre, Ontario Health, Toronto, Canada
| | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czechia
| | | | - Vladimir Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czechia
| | | | - Eleonora Fabianova
- Regional Authority of Public Health, Banská Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | | | - Bas Bueno-de-Mesquita
- Former senior scientist, Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Kurt Straif
- ISGlobal, Barcelona, Spain
- Boston College, Massachusetts
| |
Collapse
|
8
|
Gu J, Deffner V, Küchenhoff H, Pickford R, Breitner S, Schneider A, Kowalski M, Peters A, Lutz M, Kerschbaumer A, Slama R, Morelli X, Wichmann HE, Cyrys J. Low emission zones reduced PM 10 but not NO 2 concentrations in Berlin and Munich, Germany. J Environ Manage 2022; 302:114048. [PMID: 34872181 DOI: 10.1016/j.jenvman.2021.114048] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Revised: 10/20/2021] [Accepted: 10/30/2021] [Indexed: 06/13/2023]
Abstract
Low emission zones (LEZs) aiming at improving the air quality in urban areas have been implemented in many European cities. However, studies are limited in evaluating the effects of LEZ, and most of which used simple methods. In this study, a general additive mixed model was utilized to account for confounders in the atmosphere and validate the effects of LEZ on PM10 and NO2 concentrations in two German cities. In addition, the effects of LEZ on elemental carbon (EC) and total carbon (TC) in Berlin were also evaluated. The LEZ effects were estimated after taking into account air pollutant concentrations at a reference site located in the regional background, and adjusting for hour of the week, public holidays, season, and wind direction. The LEZ in Berlin, and the LEZ in combination with the heavy-duty vehicle (HDV) transit ban in Munich significantly reduced the PM10 concentrations, at both traffic sites (TS) and urban background sites (UB). The effects were greater in LEZ stage 3 than in LEZ stages 2 and 1. Moreover, compared with PM10, LEZ was more efficient in reducing EC, a component that is considered more toxic than PM10 mass. In contrast, the LEZ had no consistent effect on NO2 levels: no effects were observed in Berlin; in Munich, the combination of the LEZ and the HDV transit ban reduced NO2 at UB site in LEZ stage 1, but without further reductions in subsequent stages of the LEZ. Overall, our study indicated that LEZs, which target the major primary air pollution source in the highly populated city center could be an effective way to improve urban air quality such as PM mass concentration and EC level.
Collapse
Affiliation(s)
- Jianwei Gu
- Institute of Environmental Health and Pollution Control, School of Environmental Science and Engineering, Guangdong University of Technology, 510006, Guangzhou, China; Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany; Environment Science Center, University of Augsburg, Universitätsstr. 1a, 86159, Augsburg, Germany.
| | - Veronika Deffner
- Statistical Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universität Munich, Akademiestr. 1, 80799, Munich, Germany
| | - Helmut Küchenhoff
- Statistical Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universität Munich, Akademiestr. 1, 80799, Munich, Germany
| | - Regina Pickford
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - Susanne Breitner
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - Alexandra Schneider
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - Michal Kowalski
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany; Environment Science Center, University of Augsburg, Universitätsstr. 1a, 86159, Augsburg, Germany
| | - Annette Peters
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - Martin Lutz
- Senate Department for the Environment, Transport and Climate Protection, Referat Immissionsschutz, Brückenstraße 6, 10179, Berlin, Germany
| | - Andreas Kerschbaumer
- Senate Department for the Environment, Transport and Climate Protection, Referat Immissionsschutz, Brückenstraße 6, 10179, Berlin, Germany
| | - Rémy Slama
- Inserm, CNRS, University Grenoble-Alpes, Institute of Advanced Biosciences (IAB) Joint Research Center, Team of Environmental Epidemiology, Grenoble, La Tronche, France
| | - Xavier Morelli
- Inserm, CNRS, University Grenoble-Alpes, Institute of Advanced Biosciences (IAB) Joint Research Center, Team of Environmental Epidemiology, Grenoble, La Tronche, France
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - Josef Cyrys
- Institute of Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
| |
Collapse
|
9
|
Hovanec J, Siemiatycki J, Conway DI, Olsson A, Guenel P, Luce D, Jöckel KH, Pohlabeln H, Ahrens W, Karrasch S, Wichmann HE, Gustavsson P, Consonni D, Merletti F, Richiardi L, Lorenzo S, Fortes C, Parent MÉ, McLaughlin JR, Demers P, Landi MT, Caporaso N, Fernández-Tardón G, Zaridze D, Świątkowska B, Pándics T, Lissowska J, Fabianova E, Field JK, Mates D, Bencko V, Foretova L, Janout V, Kromhout H, Vermeulen R, Boffetta P, Straif K, Schüz J, Casjens S, Pesch B, Brüning T, Behrens T. Application of two job indices for general occupational demands in a pooled analysis of case-control studies on lung cancer. Scand J Work Environ Health 2021; 47:475-481. [PMID: 33942106 PMCID: PMC8504542 DOI: 10.5271/sjweh.3967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Objectives: We investigated general job demands as a risk factor for lung cancer as well as their role in the association between occupational prestige and lung cancer. Methods: In 13 case–control studies on lung cancer, as part of the international SYNERGY project, we applied indices for physical (PHI) and psychosocial (PSI) job demands – each with four categories (high to low). We estimated odds ratios (OR) and 95% confidence intervals (CI) for lung cancer by unconditional logistic regression, separately for men and women and adjusted for study centre, age, smoking behavior, and former employment in occupations with potential exposure to carcinogens. Further, we investigated, whether higher risks among men with low occupational prestige (Treiman’s Standard International Occupational Prestige Scale) were affected by adjustment for the job indices. Results: In 30 355 men and 7371 women, we found increased risks (OR) for lung cancer with high relative to low job demands in both men [PHI 1.74 (95% CI 1.56–1.93), PSI 1.33 (95% CI 1.17–1.51)] and women [PHI 1.62 (95% CI 1.24–2.11), PSI 1.31 (95% CI 1.09–1.56)]. OR for lung cancer among men with low occupational prestige were slightly reduced when adjusting for PHI [low versus high prestige OR from 1.44 (95% CI 1.32–1.58) to 1.30 (95% CI 1.17–1.45)], but not PSI. Conclusions: Higher physical job demands were associated with increased risks of lung cancer, while associations for higher psychosocial demands were less strong. In contrast to physical demands, psychosocial demands did not contribute to clarify the association of occupational prestige and lung cancer.
Collapse
Affiliation(s)
- Jan Hovanec
- Jan Hovanec, IPA, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Guha N, Bouaoun L, Kromhout H, Vermeulen R, Brüning T, Behrens T, Peters S, Luzon V, Siemiatycki J, Xu M, Kendzia B, Guenel P, Luce D, Karrasch S, Wichmann HE, Consonni D, Landi MT, Caporaso NE, Gustavsson P, Plato N, Merletti F, Mirabelli D, Richiardi L, Jöckel KH, Ahrens W, Pohlabeln H, Tse LA, Yu ITS, Tardón A, Boffetta P, Zaridze D, 't Mannetje A, Pearce N, Davies MPA, Lissowska J, Świątkowska B, McLaughlin J, Demers PA, Bencko V, Foretova L, Janout V, Pándics T, Fabianova E, Mates D, Forastiere F, Bueno-de-Mesquita B, Schüz J, Straif K, Olsson A. Lung cancer risk in painters: results from the SYNERGY pooled case-control study consortium. Occup Environ Med 2021; 78:269-278. [PMID: 33115922 PMCID: PMC7958079 DOI: 10.1136/oemed-2020-106770] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 09/02/2020] [Accepted: 09/29/2020] [Indexed: 12/03/2022]
Abstract
OBJECTIVES We evaluated the risk of lung cancer associated with ever working as a painter, duration of employment and type of painter by histological subtype as well as joint effects with smoking, within the SYNERGY project. METHODS Data were pooled from 16 participating case-control studies conducted internationally. Detailed individual occupational and smoking histories were available for 19 369 lung cancer cases (684 ever employed as painters) and 23 674 age-matched and sex-matched controls (532 painters). Multivariable unconditional logistic regression models were adjusted for age, sex, centre, cigarette pack-years, time-since-smoking cessation and lifetime work in other jobs that entailed exposure to lung carcinogens. RESULTS Ever having worked as a painter was associated with an increased risk of lung cancer in men (OR 1.30; 95% CI 1.13 to 1.50). The association was strongest for construction and repair painters and the risk was elevated for all histological subtypes, although more evident for small cell and squamous cell lung cancer than for adenocarcinoma and large cell carcinoma. There was evidence of interaction on the additive scale between smoking and employment as a painter (relative excess risk due to interaction >0). CONCLUSIONS Our results by type/industry of painter may aid future identification of causative agents or exposure scenarios to develop evidence-based practices for reducing harmful exposures in painters.
Collapse
Affiliation(s)
- Neela Guha
- International Agency for Research on Cancer, Lyon, France
- California Environmental Protection Agency, Oakland, California, USA
| | | | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | | | - Jack Siemiatycki
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada
| | - Mengting Xu
- Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany
| | - Pascal Guenel
- Center for Research in Epidemiology and Population Health (CESP), Exposome and Heredity team, Inserm U1018, University Paris-Saclay, Villejuif, France
| | - Danièle Luce
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France
| | - Stefan Karrasch
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Inner City Clinic, University Hospital of Munich, Ludwig-Maximilians-Universität; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munchen, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig Maximilians University, Munich, Germany
- Institut für Epidemiologie, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany
| | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - Maria Teresa Landi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
| | - Neil E Caporaso
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
| | - Per Gustavsson
- Institute of Environmental Medicine, Unit of Occupational Medicine, Karolinska Institute, Stockholm, Sweden
| | - Nils Plato
- Institute of Environmental Medicine, Unit of Occupational Medicine, Karolinska Institute, Stockholm, Sweden
| | - Franco Merletti
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Dario Mirabelli
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, Essen, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
- Faculty of Mathematics and Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
| | - Lap Ah Tse
- JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong
| | - Ignatius Tak-Sun Yu
- JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong
| | - Adonina Tardón
- Department of Public Health, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain
| | - Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - David Zaridze
- Department of Cancer Epidemiology and Prevention, N.N. Blokhin National Research Centre of Oncology, Moscow, Russian Federation
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Neil Pearce
- Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
| | - Michael P A Davies
- Department of Molecular and Clinical Cancer Medicine, University of Liverpool. Roy Castle Lung Cancer Foundation, Liverpool, UK
| | - Jolanta Lissowska
- Epidemiology Unit, Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Beata Świątkowska
- Health Capital School; Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland
| | - John McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Paul A Demers
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Occupational Cancer Research Centre, Ontario Health, Toronto, Ontario, Canada
| | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Lenka Foretova
- Masaryk Memorial Cancer Institute, Brno, Jihomoravský, Czech Republic
| | - Vladimir Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
| | | | - Eleonora Fabianova
- Occupational Health and Toxicology, Regional Authority of Public Health, Banska Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | | | - Bas Bueno-de-Mesquita
- Former senior scientist, Department for Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Joachim Schüz
- International Agency for Research on Cancer, Lyon, France
| | - Kurt Straif
- International Agency for Research on Cancer, Lyon, France
| | - Ann Olsson
- International Agency for Research on Cancer, Lyon, France
| |
Collapse
|
11
|
Ge C, Peters S, Olsson A, Portengen L, Schüz J, Almansa J, Behrens T, Pesch B, Kendzia B, Ahrens W, Bencko V, Benhamou S, Boffetta P, Bueno-de-Mesquita B, Caporaso N, Consonni D, Demers P, Fabiánová E, Fernández-Tardón G, Field J, Forastiere F, Foretova L, Guénel P, Gustavsson P, Ho V, Janout V, Jöckel KH, Karrasch S, Landi MT, Lissowska J, Luce D, Mates D, McLaughlin J, Merletti F, Mirabelli D, Plato N, Pohlabeln H, Richiardi L, Rudnai P, Siemiatycki J, Świątkowska B, Tardón A, Wichmann HE, Zaridze D, Brüning T, Straif K, Kromhout H, Vermeulen R. Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies. Am J Respir Crit Care Med 2020; 202:412-421. [PMID: 32330394 PMCID: PMC7465090 DOI: 10.1164/rccm.201910-1926oc] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Accepted: 04/24/2020] [Indexed: 11/16/2022] Open
Abstract
Rationale: Millions of workers around the world are exposed to respirable crystalline silica. Although silica is a confirmed human lung carcinogen, little is known regarding the cancer risks associated with low levels of exposure and risks by cancer subtype. However, little is known regarding the disease risks associated with low levels of exposure and risks by cancer subtype.Objectives: We aimed to address current knowledge gaps in lung cancer risks associated with low levels of occupational silica exposure and the joint effects of smoking and silica exposure on lung cancer risks.Methods: Subjects from 14 case-control studies from Europe and Canada with detailed smoking and occupational histories were pooled. A quantitative job-exposure matrix was used to estimate silica exposure by occupation, time period, and geographical region. Logistic regression models were used to estimate exposure-disease associations and the joint effects of silica exposure and smoking on risk of lung cancer. Stratified analyses by smoking history and cancer subtypes were also performed.Measurements and Main Results: Our study included 16,901 cases and 20,965 control subjects. Lung cancer odds ratios ranged from 1.15 (95% confidence interval, 1.04-1.27) to 1.45 (95% confidence interval, 1.31-1.60) for groups with the lowest and highest cumulative exposure, respectively. Increasing cumulative silica exposure was associated (P trend < 0.01) with increasing lung cancer risks in nonsilicotics and in current, former, and never-smokers. Increasing exposure was also associated (P trend ≤ 0.01) with increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. Supermultiplicative interaction of silica exposure and smoking was observed on overall lung cancer risks; superadditive effects were observed in risks of lung cancer and all three included subtypes.Conclusions: Silica exposure is associated with lung cancer at low exposure levels. An exposure-response relationship was robust and present regardless of smoking, silicosis status, and cancer subtype.
Collapse
Affiliation(s)
- Calvin Ge
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Ann Olsson
- International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France
| | - Lützen Portengen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France
| | - Josué Almansa
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany
| | - Beate Pesch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology-Bremen Institute for Prevention Research and Social Medicine (BIPS), Bremen, Germany
| | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Paolo Boffetta
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Bas Bueno-de-Mesquita
- The National Institute for Public Health and Environmental Protection, Bilthoven, the Netherlands
| | | | - Dario Consonni
- Unità di epidemiologia, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Paul Demers
- Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada
| | - Eleonóra Fabiánová
- Regional Authority of Public Health, Banská Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Guillermo Fernández-Tardón
- Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Institute of Health Research of the Principality of Asturias-Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Faculty of Medicine, University of Oviedo, Oviedo, Spain
| | - John Field
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
| | - Francesco Forastiere
- Consiglio Nazionale delle Ricerche-Istituto per la Ricerca e l’Innovazione Biomedica (CNR-Irib), Palermo, Italy
| | | | - Pascal Guénel
- Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, Inserm Unit 1018, University Paris-Saclay, Villejuif, France
| | - Per Gustavsson
- The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - Vikki Ho
- University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada
| | - Vladimir Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry, and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Stefan Karrasch
- Institute and Outpatient Clinic for Occupational, Social, and Environmental Medicine, Inner City Clinic, University Hospital of Munich and
- Institute of Epidemiology, Helmholtz Zentrum München–German Research Center for Environmental Health, Neuherberg, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Neuherberg, Germany
| | | | - Jolanta Lissowska
- The M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Danièle Luce
- Université de Rennes I, Inserm Unit 1085, École des hautes études en santé publique (EHESP), Institut de recherche en santé, environnement et travail (Irset), Pointe-à-Pitre, France
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | - John McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Dario Mirabelli
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Nils Plato
- The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology-Bremen Institute for Prevention Research and Social Medicine (BIPS), Bremen, Germany
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Peter Rudnai
- National Public Health Center, Budapest, Hungary
| | - Jack Siemiatycki
- University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada
| | | | - Adonina Tardón
- Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Institute of Health Research of the Principality of Asturias-Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Faculty of Medicine, University of Oviedo, Oviedo, Spain
| | - Heinz-Erich Wichmann
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig-Maximilians-Universität, Munich, Germany
- Institut für Epidemiologie, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; and
| | | | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany
| | - Kurt Straif
- International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| |
Collapse
|
12
|
Ge C, Peters S, Olsson A, Portengen L, Schüz J, Almansa J, Ahrens W, Bencko V, Benhamou S, Boffetta P, Bueno-de-Mesquita B, Caporaso N, Consonni D, Demers P, Fabiánová E, Fernández-Tardón G, Field J, Forastiere F, Foretova L, Guénel P, Gustavsson P, Janout V, Jöckel KH, Karrasch S, Teresa Landi M, Lissowska J, Luce D, Mates D, McLaughlin J, Merletti F, Mirabelli D, Pándics T, Parent MÉ, Plato N, Pohlabeln H, Richiardi L, Siemiatycki J, Świątkowska B, Tardón A, Wichmann HE, Zaridze D, Straif K, Kromhout H, Vermeulen R. Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies. Am J Respir Crit Care Med 2020; 202:402-411. [PMID: 32330395 PMCID: PMC7465091 DOI: 10.1164/rccm.201911-2101oc] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2019] [Accepted: 04/24/2020] [Indexed: 11/16/2022] Open
Abstract
Rationale: Although the carcinogenicity of diesel engine exhaust has been demonstrated in multiple studies, little is known regarding exposure-response relationships associated with different exposure subgroups and different lung cancer subtypes.Objectives: We expanded on a previous pooled case-control analysis on diesel engine exhaust and lung cancer by including three additional studies and quantitative exposure assessment to evaluate lung cancer and subtype risks associated with occupational exposure to diesel exhaust characterized by elemental carbon (EC) concentrations.Methods: We used a quantitative EC job-exposure matrix for exposure assessment. Unconditional logistic regression models were used to calculate lung cancer odds ratios and 95% confidence intervals (CIs) associated with various metrics of EC exposure. Lung cancer excess lifetime risks (ELR) were calculated using life tables accounting for all-cause mortality. Additional stratified analyses by smoking history and lung cancer subtypes were performed in men.Measurements and Main Results: Our study included 16,901 lung cancer cases and 20,965 control subjects. In men, exposure response between EC and lung cancer was observed: odds ratios ranged from 1.09 (95% CI, 1.00-1.18) to 1.41 (95% CI, 1.30-1.52) for the lowest and highest cumulative exposure groups, respectively. EC-exposed men had elevated risks in all lung cancer subtypes investigated; associations were strongest for squamous and small cell carcinomas and weaker for adenocarcinoma. EC lung cancer exposure response was observed in men regardless of smoking history, including in never-smokers. ELR associated with 45 years of EC exposure at 50, 20, and 1 μg/m3 were 3.0%, 0.99%, and 0.04%, respectively, for both sexes combined.Conclusions: We observed a consistent exposure-response relationship between EC exposure and lung cancer in men. Reduction of workplace EC levels to background environmental levels will further reduce lung cancer ELR in exposed workers.
Collapse
Affiliation(s)
- Calvin Ge
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Ann Olsson
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Lützen Portengen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Josué Almansa
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Wolfgang Ahrens
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
| | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Paolo Boffetta
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Bas Bueno-de-Mesquita
- The National Institute for Public Health and Environmental Protection, Bilthoven, the Netherlands
| | | | - Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Paul Demers
- Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada
| | - Eleonóra Fabiánová
- Regional Authority of Public Health, Banská Bystrica, Slovakia
- Faculty of Health, Catholic University, Ružomberok, Slovakia
| | - Guillermo Fernández-Tardón
- Fundación para la Investigación e Innovación Biomédica en el Principado de Asturias – Instituto de Investigación Sanitaria del Principado (FINBA-ISPA), Faculty of Medicine, University of Oviedo and Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Oviedo, Spain
| | - John Field
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
| | - Francesco Forastiere
- Consiglio Nazionale delle Ricerche-Istituto per la Ricerca e l’Innovazione Biomedica (CNR-Irib), Palermo, Italy
| | | | - Pascal Guénel
- Center for research in Epidemiology and Population Health (CESP), Cancer and Environment team, Inserm U1018, University Paris-Sud, University Paris-Saclay, Villejuif, France
| | - Per Gustavsson
- The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Vladimir Janout
- Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Stefan Karrasch
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Inner City Clinic, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany
- Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Neuherberg, Germany
| | | | - Jolanta Lissowska
- The M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Danièle Luce
- Univ Rennes, Inserm, Ecole des hautes études en santé publique (EHESP), Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France
| | - Dana Mates
- National Institute of Public Health, Bucharest, Romania
| | - John McLaughlin
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy
| | - Dario Mirabelli
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy
| | | | - Marie-Élise Parent
- Institut national de la recherche scientifique, University of Quebec, Laval, Quebec, Canada
| | - Nils Plato
- The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Hermann Pohlabeln
- Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy
| | - Jack Siemiatycki
- University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada
| | | | - Adonina Tardón
- Fundación para la Investigación e Innovación Biomédica en el Principado de Asturias – Instituto de Investigación Sanitaria del Principado (FINBA-ISPA), Faculty of Medicine, University of Oviedo and Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Oviedo, Spain
| | - Heinz-Erich Wichmann
- Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig Maximilians University, Munich, Germany
- Institut für Epidemiologie, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; and
| | | | - Kurt Straif
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| |
Collapse
|
13
|
Langer S, Horn J, Kluttig A, Mikolajczyk R, Karrasch S, Schulz H, Wichmann HE, Linseisen J, Jaeschke L, Pischon T, Fricke J, Keil T, Ahrens W, Günther K, Kuß O, Schikowski T, Schmidt B, Jöckel KH, Michels KB, Franzke CW, Becher H, Jagodzinski A, Castell S, Kemmling Y, Lieb W, Waniek S, Wirkner K, Löffler M, Kaaks R, Greiser KH, Berger K, Legath N, Meinke-Franze C, Schipf S, Leitzmann M, Baurecht H, Weigl K, Amitay E, Gottschick C. [Occurrence of bronchial asthma and age at initial asthma diagnosis-first results of the German National Cohort]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63:397-403. [PMID: 32125462 DOI: 10.1007/s00103-020-03105-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Asthma is one of the most common chronic diseases in both children and adults. Asthma first occurring in adulthood (adult-onset asthma, AOA) is associated with poorer prognosis compared to childhood-onset asthma (COA), which urgently calls for more research in this area. The aim of this work was to analyze the data on asthma collected in the German National Cohort and compare it with the German Health Interview and Examination Survey for Adults (DEGS), in particular regarding AOA. MATERIAL AND METHODS Our analysis was based on the dataset of the main questionnaire at mid-term of the German National Cohort baseline examination, comprising 101,723 participants. Variables considered in the analyses were self-reported diagnosis of asthma, age at first diagnosis, asthma treatment in the past 12 months, age, and sex. RESULTS In the midterm dataset, 8.7% of women and 7.0% of men in the German National Cohort reported that they had ever been diagnosed with asthma. Approximately one third of participants with asthma received their initial diagnosis before their 18th birthday. COA affected 2.2% of women and 2.8% of men, whereas AOA affected 6.5% of women and 4.2% of men. During the previous 12 months, 33% of COA cases and 60% of AOA cases were medically treated. CONCLUSION The proportion of persons affected by asthma in the German National Cohort, as well as observed patterns regarding age and gender, corresponds to other data sources such as DEGS. However, in our analysis, the proportion of individuals with AOA was higher than described in the literature. The increase in cumulative asthma diagnoses with age is markedly steeper in younger participants, indicating a rising trend over time.
Collapse
Affiliation(s)
- Susan Langer
- Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Deutschland
| | - Johannes Horn
- Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Deutschland
| | - Alexander Kluttig
- Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Deutschland
| | - Rafael Mikolajczyk
- Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Deutschland
| | - Stefan Karrasch
- Institut für Epidemiologie, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, München, Deutschland.,Institut und Poliklinik für Arbeits‑, Sozial- und Umweltmedizin, Klinikum der Universität München, München, Deutschland.,Comprehensive Pneumology Center Munich (CPC-M), Mitglied des Deutschen Zentrums für Lungenforschung (DZL), München, Deutschland
| | - Holger Schulz
- Institut für Epidemiologie, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, München, Deutschland.,Comprehensive Pneumology Center Munich (CPC-M), Mitglied des Deutschen Zentrums für Lungenforschung (DZL), München, Deutschland
| | - Heinz-Erich Wichmann
- Institut für Epidemiologie, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, München, Deutschland
| | - Jakob Linseisen
- Ludwig-Maximilians-Universität München, Lehrstuhl für Epidemiologie, UNIKA-T Augsburg, Augsburg, Deutschland.,Klinische Epidemiologie, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, München, Deutschland
| | - Lina Jaeschke
- Forschergruppe Molekulare Epidemiologie, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Berlin, Deutschland
| | - Tobias Pischon
- Forschergruppe Molekulare Epidemiologie, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Berlin, Deutschland.,Charité - Universitätsmedizin Berlin, Berlin, Deutschland.,Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Partnerstandort Berlin, Berlin, Deutschland.,MDC/BIH Biobank, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) und Berlin Institute of Health (BIH), Berlin, Deutschland
| | - Julia Fricke
- Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Universitätsmedizin Berlin, Berlin, Deutschland
| | - Thomas Keil
- Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Universitätsmedizin Berlin, Berlin, Deutschland.,Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg, Würzburg, Deutschland.,Landesinstitut für Gesundheit, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Bad Kissingen, Deutschland
| | - Wolfgang Ahrens
- Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Bremen, Deutschland.,Institut für Statistik, Fachbereich Mathematik und Informatik, Universität Bremen, Bremen, Deutschland
| | - Kathrin Günther
- Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Bremen, Deutschland
| | - Oliver Kuß
- Leibniz-Zentrum für Diabetes-Forschung an der Heinrich-Heine-Universität Düsseldorf, Institut für Biometrie und Epidemiologie, Deutsches Diabetes-Zentrum (DDZ), Düsseldorf, Deutschland
| | - Tamara Schikowski
- IUF - Leibniz-Institut für umweltmedizinische Forschung gGmbH, Düsseldorf, Deutschland
| | - Börge Schmidt
- Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, Essen, Deutschland
| | - Karl-Heinz Jöckel
- Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, Essen, Deutschland
| | - Karin B Michels
- Institut für Prävention und Tumorepidemiologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland
| | - Claus-Werner Franzke
- Institut für Prävention und Tumorepidemiologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland
| | - Heiko Becher
- Institut für Medizinische Biometrie und Epidemiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
| | - Annika Jagodzinski
- Klinik für Allgemeine und Interventionelle Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg - Eppendorf, Hamburg, Deutschland.,Deutsches Zentrum für Herzkreislaufforschung, Hamburg, Deutschland.,Epidemiologisches Studienzentrum, Universitätsklinikum Hamburg - Eppendorf, Hamburg, Deutschland
| | - Stefanie Castell
- Helmholtz-Zentrum für Infektionsforschung, Braunschweig, Deutschland
| | - Yvonne Kemmling
- Helmholtz-Zentrum für Infektionsforschung, Braunschweig, Deutschland
| | - Wolfgang Lieb
- Institut für Epidemiologie, Christian-Albrechts-Universität Kiel, Kiel, Deutschland
| | - Sabina Waniek
- Institut für Epidemiologie, Christian-Albrechts-Universität Kiel, Kiel, Deutschland
| | - Kerstin Wirkner
- Institut für Medizinische Informatik, Statistik und Epidemiologie (IMISE), Universität Leipzig, Leipzig, Deutschland.,LIFE-Forschungszentrum für Zivilisationskrankheiten, Universität Leipzig, Leipzig, Deutschland
| | - Markus Löffler
- Institut für Medizinische Informatik, Statistik und Epidemiologie (IMISE), Universität Leipzig, Leipzig, Deutschland.,LIFE-Forschungszentrum für Zivilisationskrankheiten, Universität Leipzig, Leipzig, Deutschland
| | - Rudolf Kaaks
- Abteilung Epidemiologie von Krebserkrankungen, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland
| | - Karin Halina Greiser
- Abteilung Epidemiologie von Krebserkrankungen, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland
| | - Klaus Berger
- Institut für Epidemiologie und Sozialmedizin, Westfälische Wilhelms-Universität Münster, Münster, Deutschland
| | - Nicole Legath
- Institut für Epidemiologie und Sozialmedizin, Westfälische Wilhelms-Universität Münster, Münster, Deutschland
| | - Claudia Meinke-Franze
- Institut für Community Medicine, Universitätsmedizin Greifswald, Greifswald, Deutschland
| | - Sabine Schipf
- Institut für Community Medicine, Universitätsmedizin Greifswald, Greifswald, Deutschland
| | - Michael Leitzmann
- Institut für Epidemiologie und Präventivmedizin, Universität Regensburg, Regensburg, Deutschland
| | - Hansjörg Baurecht
- Institut für Epidemiologie und Präventivmedizin, Universität Regensburg, Regensburg, Deutschland
| | - Korbinian Weigl
- Abt. Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland
| | - Efrat Amitay
- Abt. Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland
| | - Cornelia Gottschick
- Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Deutschland.
| |
Collapse
|
14
|
Pesch B, Kendzia B, Pohlabeln H, Ahrens W, Wichmann HE, Siemiatycki J, Taeger D, Zschiesche W, Behrens T, Jöckel KH, Brüning T. Exposure to Welding Fumes, Hexavalent Chromium, or Nickel and Risk of Lung Cancer. Am J Epidemiol 2019; 188:1984-1993. [PMID: 31504103 DOI: 10.1093/aje/kwz187] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2018] [Revised: 08/13/2019] [Accepted: 08/13/2019] [Indexed: 11/13/2022] Open
Abstract
To investigate the risk of lung cancer after exposure to welding fumes, hexavalent chromium (Cr(VI)), and nickel, we analyzed 3,418 lung cancer cases and 3,488 controls among men from 2 German case-control studies (1988-1996). We developed a welding-process exposure matrix from measurements of these agents, and this was linked with welding histories from a job-specific questionnaire to calculate cumulative exposure variables. Logistic regression models were fitted to estimate odds ratios with confidence intervals conditional on study, and they adjusted for age, smoking, and working in other at-risk occupations. Additionally, we mutually adjusted for the other exposure variables under study. Overall, 800 cases and 645 controls ever worked as regular or occasional welders. Odds ratios for lung cancer with high exposure were 1.55 (95% confidence interval (CI): 1.17, 2.05; median, 1.8 mg/m3 × years) for welding fumes, 1.85 (95% CI: 1.35, 2.54; median, 1.4 μg/m3 × years) for Cr(VI), and 1.60 (95% CI: 1.21, 2.12; median, 9 μg/m3 × years) for nickel. Risk estimates increased with increasing cumulative exposure to welding fumes and with increasing exposure duration for Cr(VI) and nickel. Our results showed that welding fumes, Cr(VI), and nickel might contribute independently to the excess lung cancer risk associated with welding. However, quantitative exposure assessment remains challenging.
Collapse
|
15
|
Plaß D, Tobollik M, Devleesschauwer B, Grill E, Hoffmann B, Hurraß J, Künzli N, Peters A, Rothenbacher D, Schneider A, Wichmann HE, Wintermeyer D, Wolf J, Zeeb H, Straff W. Kritik an Population Attributable Fraction bei genauerem Hinsehen nicht gerechtfertigt. Gesundheitswesen 2019; 81:444-447. [DOI: 10.1055/a-0915-1215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- D Plaß
- Umweltbundesamt, Abteilung Umwelthygiene, Berlin
| | - M Tobollik
- Umweltbundesamt, Abteilung Umwelthygiene, Berlin
| | - B Devleesschauwer
- Sciensano, Abteilung für Epidemiologie und Public Health, (Belgisches Institut für Gesundheit), Brüssel, Belgien
| | - E Grill
- Institut für Medizinische Informationsverarbeitung Biometrie und Epidemiologie (IBE), Ludwig-Maximilians Universität München, München
| | - B Hoffmann
- Institut für Arbeits-, Sozial- und Umweltmedizin, Medizinische Fakultät, Universität Düsseldorf, Düsseldorf
| | - J Hurraß
- Umweltbundesamt, Abteilung Umwelthygiene, Berlin
| | - N Künzli
- Schweizerisches Tropen- und Public Health-Institut, Basel, Schweiz
| | - A Peters
- Institut für Epidemiologie, Helmholtz Zentrum München und Institut für Medizinische Informationsverarbeitung Biometrie und Epidemiologie (IBE), Ludwig-Maximilians Universität München, München
| | - D Rothenbacher
- Institut für Epidemiologie und Medizinische Biometrie, Universität Ulm, Ulm
| | - A Schneider
- Institut für Epidemiologie, Helmholtz Zentrum München, München
| | - H E Wichmann
- ehemals Institut für Epidemiologie, Helmholtz Zentrum München, München und Lehrstuhl für Epidemiologie, LMU München
| | | | - J Wolf
- Unabhängige Beraterin (Derzeit Weltgesundheitsorganisation, Genf, Schweiz)
| | - H Zeeb
- Abteilung Prävention und Evaluation, Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS, Bremen
| | - W Straff
- Umweltbundesamt, Abteilung Umwelthygiene, Berlin
| |
Collapse
|
16
|
Hovanec J, Siemiatycki J, Conway DI, Olsson A, Stücker I, Guida F, Jöckel KH, Pohlabeln H, Ahrens W, Brüske I, Wichmann HE, Gustavsson P, Consonni D, Merletti F, Richiardi L, Simonato L, Fortes C, Parent ME, McLaughlin J, Demers P, Landi MT, Caporaso N, Tardón A, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Field J, Dumitru RS, Bencko V, Foretova L, Janout V, Kromhout H, Vermeulen R, Boffetta P, Straif K, Schüz J, Kendzia B, Pesch B, Brüning T, Behrens T. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PLoS One 2018; 13:e0192999. [PMID: 29462211 PMCID: PMC5819792 DOI: 10.1371/journal.pone.0192999] [Citation(s) in RCA: 76] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2016] [Accepted: 02/02/2018] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND An association between low socioeconomic status (SES) and lung cancer has been observed in several studies, but often without adequate control for smoking behavior. We studied the association between lung cancer and occupationally derived SES, using data from the international pooled SYNERGY study. METHODS Twelve case-control studies from Europe and Canada were included in the analysis. Based on occupational histories of study participants we measured SES using the International Socio-Economic Index of Occupational Status (ISEI) and the European Socio-economic Classification (ESeC). We divided the ISEI range into categories, using various criteria. Stratifying by gender, we calculated odds ratios (OR) and 95% confidence intervals (CI) by unconditional logistic regression, adjusting for age, study, and smoking behavior. We conducted analyses by histological subtypes of lung cancer and subgroup analyses by study region, birth cohort, education and occupational exposure to known lung carcinogens. RESULTS The analysis dataset included 17,021 cases and 20,885 controls. There was a strong elevated OR between lung cancer and low SES, which was attenuated substantially after adjustment for smoking, however a social gradient persisted. SES differences in lung cancer risk were higher among men (lowest vs. highest SES category: ISEI OR 1.84 (95% CI 1.61-2.09); ESeC OR 1.53 (95% CI 1.44-1.63)), than among women (lowest vs. highest SES category: ISEI OR 1.54 (95% CI 1.20-1.98); ESeC OR 1.34 (95% CI 1.19-1.52)). CONCLUSION SES remained a risk factor for lung cancer after adjustment for smoking behavior.
Collapse
Affiliation(s)
- Jan Hovanec
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Jack Siemiatycki
- University of Montreal, Hospital Research Center (CRCHUM) and School of Public Health, Montreal, Canada
| | - David I. Conway
- Dental School, College of Medicine Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
| | - Ann Olsson
- International Agency for Research on Cancer (IARC), Lyon, France
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Isabelle Stücker
- Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, Villejuif, France
- University Paris-Sud, UMRS 1018, Villejuif, France
| | - Florence Guida
- Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, Villejuif, France
- University Paris-Sud, UMRS 1018, Villejuif, France
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
| | - Hermann Pohlabeln
- Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany
| | - Wolfgang Ahrens
- Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany
- Institute for Statistics, University Bremen, Bremen, Germany
| | - Irene Brüske
- Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany
- Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany
| | - Per Gustavsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Dario Consonni
- Unit of Epidemiology, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy
| | - Franco Merletti
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Simonato
- Laboratory of Public Health and Population Studies, Department of Molecular Medicine, University of Padova, Padova, Italy
| | - Cristina Fortes
- Epidemiology Unit, Istituto Dermopatico dell'Immacolata (IDI-IRCCS-FLMM), Rome, Italy
| | - Marie-Elise Parent
- INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada
| | | | - Paul Demers
- Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada
| | - Maria Teresa Landi
- National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, United States of America
| | - Neil Caporaso
- National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, United States of America
| | - Adonina Tardón
- Molecular Epidemiology of Cancer Unit, University of Oviedo-Ciber de Epidemiologia, CIBERESP, Oviedo, Spain
| | - David Zaridze
- Institute of Carcinogenesis, Russian Cancer Research Centre, Moscow, Russia
| | | | - Peter Rudnai
- National Centre for Public Health, Budapest, Hungary
| | - Jolanta Lissowska
- The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland
| | - Eleonora Fabianova
- Regional Authority of Public Health, Preventive Occupational Medicine, Banska Bystrica, Slovakia
| | - John Field
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
| | | | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Lenka Foretova
- Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Dept. of Cancer Epidemiology & Genetics, Brno, Czech Republic
| | - Vladimir Janout
- Palacky University, Faculty of Medicine, Olomouc, Czech Republic
- Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
| | - Hans Kromhout
- Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Roel Vermeulen
- Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Paolo Boffetta
- The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
| | - Kurt Straif
- International Agency for Research on Cancer (IARC), Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer (IARC), Lyon, France
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Beate Pesch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany
| |
Collapse
|
17
|
Abstract
Did you ever hear about epidemiology in Germany? Starting from an epidemiological desert the discipline has grown remarkably, especially during the last 10-15 years: research institutes have been established, research funding has improved, multiple curriculae in Epidemiology and Public Health are offered. This increase has been quite steep, and now the epidemiological infrastructure is much better. Several medium-sized and even big population cohorts are ongoing, and the number and quality of publications from German epidemiologists has reached a respectable level. My own career in epidemiology started in the field of environmental health. After German reunification I concentrated for many years on environmental problems in East Germany and observed the health benefits after improvement of the situation. Later, I concentrated on population-based cohorts in newborns (GINI/LISA) and adults (KORA, German National Cohort), and on biobanking. This Essay describes the development in Germany after worldwar 2, illustrated by examples of research results and build-up of epidemiological infractructures worth mentioning.
Collapse
Affiliation(s)
- Heinz-Erich Wichmann
- Institute of Epidemiology, 2, Helmholtz Center Munich, Munich, Germany. .,Chair of Epidemiology, University of Munich, Munich, Germany.
| |
Collapse
|
18
|
Kinnersley B, Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il’yasova D, Ostrom Q, Labreche K, Eckel-Passow JE, Decker PA, Labussière M, Idbaih A, Hoang-Xuan K, Stefano ALD, Mokhtari K, Delattre JY, Galan P, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Wichmann HE, Schreiber S, Swerdlow A, Lathrop M, Simon M, Sanson M, Rajaraman P, Chanock S, Linet M, Wang Z, Yeager M, Lai RK, Claus EB, Olson SH, Jenkins RB, Houlston RS, Bondy ML. Abstract 1302: Genome-wide association study of glioma reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-1302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: Glioma accounts for ~27% of all primary brain tumors and is responsible for ~13,000 cancer-related deaths in the US each year. Glioma tumors can be broadly classified into glioblastoma (GBM) and lower-grade non-GBM. Typically gliomas have a poor prognosis irrespective of medical care, with the most common form, GBM, having a five-year survival rate of only 5%. While genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, individual studies have had limited power to identify risk loci.
METHODS: We performed the largest glioma GWAS to date, comprising a meta-analysis of six existing GWAS (6,405 cases, 14,100 controls) as well as new GWAS from the Glioma International Case Control Consortium (GICC; 4,572 cases and 3,286 controls) and University of California, San Francisco (UCSF)-Mayo (1,519 cases, 804 controls), totaling 12,496 cases (6,191 classified as GBM, 5,819 as non-GBM) and 18,190 controls.
RESULTS: We identified five new risk loci for GBM at 1p31.3 (rs12752552; near JAK1, P=2.04×10-9, odds ratio (OR)=1.22), 11q14.1 (rs11233250; P=9.95×10-10, OR=1.24), 16p13.3 (rs2562152; near MPG, P=1.93x10-8, OR=1.21), 16q12.1 (rs10852606; HEATR3, P=1.29×10-11, OR=1.18), 22q13.1 (rs2235573; P=1.76×10-10, OR=1.15) and eight for non-GBM at 1q32.1 (rs4252707; MDM4, P=3.34×10-9, OR=1.19), 1q44 (rs12076373; AKT3, P=2.63×10-10, OR=1.23), 2q33.3 (rs7572263; near IDH1, P=2.18×10-10, OR=1.20), 3p14.1 (rs11706832; LRIG1, P=7.66×10-9, OR=1.15), 10q24.33 (rs11598018; OBFC1, P=3.39×10-8, OR=1.14), 11q21 (rs7107785; P=3.87×10-10, OR=1.16), 14q12 (rs10131032; P=5.07x10-11, OR=1.33) and 16p13.3 (rs3751667; P=2.61×10-9, OR=1.18). Case-only analyses confirmed the specificity of 11q14.1, 16p13.3 and 22q13.1 associations for GBM and 1q44, 2q33.3, 3p14.1, 11q21 and 14q12 for non-GBM tumors. In the combined meta-analysis, among previously published glioma risk SNPs, those for all glioma at 17p13.1 (TP53), GBM at 5p15.33 (TERT), 7p11.2 (EGFR), 9p21.3 (CDKN2B-AS1) and 20q13.33 (RTEL1) and for non-GBM at 8q24.21 (CCDC26), 11q23.2, 11q23.3 (PHLDB1) and 15q24.2 (ETFA) showed even greater evidence for association. SNPs at 10q25.2 and 12q12.1 for non-GBM tumors retained genome-wide significance (i.e. P<5.0x10-8). Associations at the previously reported loci for GBM at 3q26.2 (near TERC) and 12q23.33 (POLR3B) did not retain statistical significance.
CONCLUSIONS: Our findings substantiate genetic susceptibility to GBM and non-GBM glioma being highly distinct, consistent with their distinctive molecular profiles presumably resulting from different etiological pathways. Functional analyses should lead to further insights into the biological basis of the different glioma histologies. Such information can inform gene discovery initiatives and therefore have a measurable impact on the successful development of new therapeutic agents.
Citation Format: Ben Kinnersley, Beatrice S. Melin, Jill S. Barnholtz-Sloan, Margaret R. Wrensch, Christoffer Johansen, Dora Il’yasova, Quinn Ostrom, and members of GICC, Karim Labreche, Jeanette E. Eckel-Passow, Paul A. Decker, Marianne Labussière, Ahmed Idbaih, Khe Hoang-Xuan, Anna-Luisa Di Stefano, Karima Mokhtari, Jean-Yves Delattre, Pilar Galan, Konstantinos Gousias, Johannes Schramm, Minouk J. Schoemaker, Sarah J. Fleming, Stefan Herms, Stefanie Heilmann, Marcus M. Nöthen, Heinz-Erich Wichmann, Stefan Schreiber, Anthony Swerdlow, Mark Lathrop, Matthias Simon, Marc Sanson, Preetha Rajaraman, Stephen Chanock, Martha Linet, Zhaoming Wang, Meredith Yeager, Rose K. Lai, Elizabeth B. Claus, Sara H. Olson, Robert B. Jenkins, Richard S. Houlston, Melissa L. Bondy. Genome-wide association study of glioma reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1302. doi:10.1158/1538-7445.AM2017-1302
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Karim Labreche
- 7Institut du cerveau et de la moelle épinière (ICM), Paris, France
| | | | | | | | - Ahmed Idbaih
- 7Institut du cerveau et de la moelle épinière (ICM), Paris, France
| | - Khe Hoang-Xuan
- 7Institut du cerveau et de la moelle épinière (ICM), Paris, France
| | | | - Karima Mokhtari
- 7Institut du cerveau et de la moelle épinière (ICM), Paris, France
| | | | - Pilar Galan
- 9Université Paris 13 Sorbonne Paris Cité, Paris, France
| | | | | | | | - Sarah J. Fleming
- 11Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, United Kingdom
| | | | | | - Marcus M. Nöthen
- 13Institute of Human Genetics, University of Bonn, Bonn, Germany
| | - Heinz-Erich Wichmann
- 14Institute of Medical Informatics, Ludwig Maximilians University, Munich, Germany
| | | | | | - Mark Lathrop
- 16Génome Québec, McGill University, Montreal, Quebec, Canada
| | | | - Marc Sanson
- 7Institut du cerveau et de la moelle épinière (ICM), Paris, France
| | | | | | | | | | | | - Rose K. Lai
- 18Keck School of Medicine, University of Southern California, Los Angeles, CA
| | | | - Sara H. Olson
- 20Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | | - Melissa L. Bondy
- 22Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | | |
Collapse
|
19
|
Pasutto F, Zenkel M, Hoja U, Berner D, Uebe S, Ferrazzi F, Schödel J, Liravi P, Ozaki M, Paoli D, Frezzotti P, Mizoguchi T, Nakano S, Kubota T, Manabe S, Salvi E, Manunta P, Cusi D, Gieger C, Wichmann HE, Aung T, Khor CC, Kruse FE, Reis A, Schlötzer-Schrehardt U. Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. Nat Commun 2017; 8:15466. [PMID: 28534485 PMCID: PMC5457519 DOI: 10.1038/ncomms15466] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 03/27/2017] [Indexed: 02/08/2023] Open
Abstract
Although lysyl oxidase-like 1 (LOXL1) is known as the principal genetic risk factor for pseudoexfoliation (PEX) syndrome, a major cause of glaucoma and cardiovascular complications, no functional variants have been identified to date. Here, we conduct a genome-wide association scan on 771 German PEX patients and 1,350 controls, followed by independent testing of associated variants in Italian and Japanese data sets. We focus on a 3.5-kb four-component polymorphic locus positioned spanning introns 1 and 2 of LOXL1 with enhancer-like chromatin features. We find that the rs11638944:C>G transversion exerts a cis-acting effect on the expression levels of LOXL1, mediated by differential binding of the transcription factor RXRα (retinoid X receptor alpha) and by modulating alternative splicing of LOXL1, eventually leading to reduced levels of LOXL1 mRNA in cells and tissues of risk allele carriers. These findings uncover a functional mechanism by which common noncoding variants influence LOXL1 expression. LOXL1 is a genetic risk factor for pseudoexfoliation syndrome of the eye but a causal variant has not been identified. Here, Pasutto et al., find intronic LOXL1 risk variants influence transcription factor binding and alternative splicing of LOXL1 in affected tissues reducing levels of LOXL1 mRNA.
Collapse
Affiliation(s)
- Francesca Pasutto
- Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 10, 91054 Erlangen, Germany
| | - Matthias Zenkel
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| | - Ursula Hoja
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| | - Daniel Berner
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| | - Steffen Uebe
- Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 10, 91054 Erlangen, Germany
| | - Fulvia Ferrazzi
- Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 10, 91054 Erlangen, Germany
| | - Johannes Schödel
- Department of Nephrology and Hypertension, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany
| | - Panah Liravi
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| | - Mineo Ozaki
- Ozaki Eye Hospital, 1-15 Kamezaki, Hyuga, Miyazaki 883-0066, Japan
| | - Daniela Paoli
- Ospedale Monfalcone, Centro Glaucomi, Via Galvani 1, 34074 Monfalcone, Italy
| | - Paolo Frezzotti
- Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Viale Bracci SNC, 53100 Siena, Italy
| | - Takanori Mizoguchi
- Mizoguchi Eye Clinic, 6-13 Tawara-machi, Sasebo, Nagasaki 857-0016, Japan
| | - Satoko Nakano
- Department of Ophthalmology, Oita University, Faculty of Medicine, 1-1 Idaigaoka, Hasana-machi, Oita 879-5593, Japan
| | - Toshiaki Kubota
- Department of Ophthalmology, Oita University, Faculty of Medicine, 1-1 Idaigaoka, Hasana-machi, Oita 879-5593, Japan
| | - Shinichi Manabe
- Hayashi Eye Hospital, 4-23-35 Hakataekimae, Hakata-ku, Fukuoka 812-0011, Japan
| | - Erika Salvi
- Department of Health Sciences, University of Milano, Via Ortles 22/4, 20139 Milano, Italy
| | - Paolo Manunta
- Department of Nephrology, University Vita-Salute San Raffaele, Via Olgettina 58, 20132 Milano, Italy
| | - Daniele Cusi
- Institute of Biomedical Technologies, National Research Centre (ITB-CNR), Via Fratelli Cervi 93, 20090 Segrate-Milano, Italy
| | - Christian Gieger
- Institute of Epidemiology, Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Munich, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology, Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Munich, Germany
| | - Tin Aung
- Singapore Eye Research Institute, Singapore National Eye Center, 11 Third Hospital Avenue, Singapore 168751, Singapore
| | | | - Friedrich E Kruse
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| | - André Reis
- Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 10, 91054 Erlangen, Germany
| | - Ursula Schlötzer-Schrehardt
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
| |
Collapse
|
20
|
Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il'yasova D, Kinnersley B, Ostrom QT, Labreche K, Chen Y, Armstrong G, Liu Y, Eckel-Passow JE, Decker PA, Labussière M, Idbaih A, Hoang-Xuan K, Di Stefano AL, Mokhtari K, Delattre JY, Broderick P, Galan P, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Wichmann HE, Schreiber S, Swerdlow A, Lathrop M, Simon M, Sanson M, Andersson U, Rajaraman P, Chanock S, Linet M, Wang Z, Yeager M, Wiencke JK, Hansen H, McCoy L, Rice T, Kosel ML, Sicotte H, Amos CI, Bernstein JL, Davis F, Lachance D, Lau C, Merrell RT, Shildkraut J, Ali-Osman F, Sadetzki S, Scheurer M, Shete S, Lai RK, Claus EB, Olson SH, Jenkins RB, Houlston RS, Bondy ML. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet 2017; 49:789-794. [PMID: 28346443 PMCID: PMC5558246 DOI: 10.1038/ng.3823] [Citation(s) in RCA: 205] [Impact Index Per Article: 29.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2016] [Accepted: 03/01/2017] [Indexed: 01/07/2023]
Abstract
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, but individual studies have had limited power to identify risk loci. We performed a meta-analysis of existing GWAS and two new GWAS, which totaled 12,496 cases and 18,190 controls. We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10-9, OR = 1.18). These data substantiate that genetic susceptibility to GBM and non-GBM tumors are highly distinct, which likely reflects different etiology.
Collapse
Affiliation(s)
| | - Jill S Barnholtz-Sloan
- Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
| | - Margaret R Wrensch
- Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, California, USA
- Institute of Human Genetics, University of California, San Francisco, San Francisco, California, USA
| | - Christoffer Johansen
- Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark and Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - Dora Il'yasova
- Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA
- Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA
- Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA
| | - Ben Kinnersley
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
| | - Quinn T Ostrom
- Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
| | - Karim Labreche
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
| | - Yanwen Chen
- Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
| | - Georgina Armstrong
- Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
| | - Yanhong Liu
- Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
| | - Jeanette E Eckel-Passow
- Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Paul A Decker
- Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Marianne Labussière
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
| | - Ahmed Idbaih
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | - Khe Hoang-Xuan
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | - Anna-Luisa Di Stefano
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | - Karima Mokhtari
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | - Jean-Yves Delattre
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | - Peter Broderick
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
| | - Pilar Galan
- Université Paris 13 Sorbonne Paris Cité, INSERM U557, INRA U1125, CNAM, Paris, France
| | | | - Johannes Schramm
- Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany
| | - Minouk J Schoemaker
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
| | - Sarah J Fleming
- Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health, University of Leeds, Leeds, UK
| | - Stefan Herms
- Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health, University of Leeds, Leeds, UK
| | | | - Markus M Nöthen
- Institute of Human Genetics, University of Bonn, Bonn, Germany
| | - Heinz-Erich Wichmann
- Helmholtz Center Munich, Institute of Epidemiology I, Munich, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany
- Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany
| | - Stefan Schreiber
- 1st Medical Department, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Anthony Swerdlow
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
- Division of Breast Cancer Research, Institute of Cancer Research, London, UK
| | - Mark Lathrop
- Génome Québec, Department of Human Genetics, McGill University, Montreal, Quebec, Canada
| | - Matthias Simon
- Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany
| | - Marc Sanson
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, Paris, France
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France
| | | | - Preetha Rajaraman
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Stephen Chanock
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Martha Linet
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Zhaoming Wang
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Meredith Yeager
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - John K Wiencke
- Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, California, USA
- Institute of Human Genetics, University of California, San Francisco, San Francisco, California, USA
| | - Helen Hansen
- Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, California, USA
| | - Lucie McCoy
- Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, California, USA
| | - Terri Rice
- Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, California, USA
| | - Matthew L Kosel
- Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Hugues Sicotte
- Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Christopher I Amos
- Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA
| | - Jonine L Bernstein
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Faith Davis
- School of Public Health, University of Alberta, Edmonton, Alberta, Canada
| | - Dan Lachance
- Department of Neurology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA
| | - Ching Lau
- Department of Pediatrics, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
| | - Ryan T Merrell
- Department of Neurology, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Joellen Shildkraut
- Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA
- Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA
| | - Francis Ali-Osman
- Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA
- Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
| | - Siegal Sadetzki
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
- Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - Michael Scheurer
- Department of Pediatrics, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
| | - Sanjay Shete
- Department of Biostatistics, University of Texas Maryland Anderson Cancer Center, Houston, Texas, USA
| | - Rose K Lai
- Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
| | - Elizabeth B Claus
- School of Public Health, Yale University, New Haven, Connecticut, USA
- Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Sara H Olson
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Robert B Jenkins
- Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA
| | - Richard S Houlston
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
- Division of Molecular Pathology, Institute of Cancer Research, London, UK
| | - Melissa L Bondy
- Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
| |
Collapse
|
21
|
Olsson AC, Vermeulen R, Schüz J, Kromhout H, Pesch B, Peters S, Behrens T, Portengen L, Mirabelli D, Gustavsson P, Kendzia B, Almansa J, Luzon V, Vlaanderen J, Stücker I, Guida F, Consonni D, Caporaso N, Landi MT, Field J, Brüske I, Wichmann HE, Siemiatycki J, Parent ME, Richiardi L, Merletti F, Jöckel KH, Ahrens W, Pohlabeln H, Plato N, Tardón A, Zaridze D, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Stanescu Dumitru R, Bencko V, Foretova L, Janout V, Boffetta P, Bueno-de-Mesquita B, Forastiere F, Brüning T, Straif K. Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies. Epidemiology 2017; 28:288-299. [PMID: 28141674 PMCID: PMC5287435 DOI: 10.1097/ede.0000000000000604] [Citation(s) in RCA: 54] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2015] [Accepted: 11/22/2016] [Indexed: 11/26/2022]
Abstract
BACKGROUND Evidence is limited regarding risk and the shape of the exposure-response curve at low asbestos exposure levels. We estimated the exposure-response for occupational asbestos exposure and assessed the joint effect of asbestos exposure and smoking by sex and lung cancer subtype in general population studies. METHODS We pooled 14 case-control studies conducted in 1985-2010 in Europe and Canada, including 17,705 lung cancer cases and 21,813 controls with detailed information on tobacco habits and lifetime occupations. We developed a quantitative job-exposure-matrix to estimate job-, time period-, and region-specific exposure levels. Fiber-years (ff/ml-years) were calculated for each subject by linking the matrix with individual occupational histories. We fit unconditional logistic regression models to estimate odds ratios (ORs), 95% confidence intervals (CIs), and trends. RESULTS The fully adjusted OR for ever-exposure to asbestos was 1.24 (95% CI, 1.18, 1.31) in men and 1.12 (95% CI, 0.95, 1.31) in women. In men, increasing lung cancer risk was observed with increasing exposure in all smoking categories and for all three major lung cancer subtypes. In women, lung cancer risk for all subtypes was increased in current smokers (ORs ~two-fold). The joint effect of asbestos exposure and smoking did not deviate from multiplicativity among men, and was more than additive among women. CONCLUSIONS Our results in men showed an excess risk of lung cancer and its subtypes at low cumulative exposure levels, with a steeper exposure-response slope in this exposure range than at higher, previously studied levels. (See video abstract at, http://links.lww.com/EDE/B161.).
Collapse
Affiliation(s)
- Ann C. Olsson
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Roel Vermeulen
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Joachim Schüz
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Hans Kromhout
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Beate Pesch
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Susan Peters
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Thomas Behrens
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Lützen Portengen
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Dario Mirabelli
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Per Gustavsson
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Benjamin Kendzia
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Josue Almansa
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Veronique Luzon
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Jelle Vlaanderen
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Isabelle Stücker
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Florence Guida
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Dario Consonni
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Neil Caporaso
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Maria Teresa Landi
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - John Field
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Irene Brüske
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Heinz-Erich Wichmann
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Jack Siemiatycki
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Marie-Elise Parent
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Lorenzo Richiardi
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Franco Merletti
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Karl-Heinz Jöckel
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Wolfgang Ahrens
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Hermann Pohlabeln
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Nils Plato
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Adonina Tardón
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - David Zaridze
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - John McLaughlin
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Paul Demers
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Neonila Szeszenia-Dabrowska
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Jolanta Lissowska
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Peter Rudnai
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Eleonora Fabianova
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Rodica Stanescu Dumitru
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Vladimir Bencko
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Lenka Foretova
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Vladimir Janout
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Paolo Boffetta
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Bas Bueno-de-Mesquita
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Francesco Forastiere
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Thomas Brüning
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| | - Kurt Straif
- From the International Agency for Research on Cancer, Lyon, France; The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy; INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Environmental epidemiology of cancer Team, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Epidemiology Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy; National Cancer Institute, Bethesda, MD; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, United Kingdom; Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany; University of Montreal Hospital Research Center (CRCHUM), Montreal, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), University of Oviedo, Oviedo, Spain; Russian Cancer Research Centre, Moscow, Russia; Public Health Ontario, Toronto, Canada; Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada; The Nofer Institute of Occupational Medicine, Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; National Centre for Public Health, Budapest, Hungary; Regional Authority of Public Health, Banska Bystrica, Slovakia; Institute of Public Health, Bucharest, Romania; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Department of Cancer Epidemiology & Genetics, Brno, Czech Republic; Faculty of Medicine, Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; and Department of Epidemiology, ASL RomaE, Rome, Italy
| |
Collapse
|
22
|
Amin N, Allebrandt KV, van der Spek A, Müller-Myhsok B, Hek K, Teder-Laving M, Hayward C, Esko T, van Mill JG, Mbarek H, Watson NF, Melville SA, Del Greco FM, Byrne EM, Oole E, Kolcic I, Chen TH, Evans DS, Coresh J, Vogelzangs N, Karjalainen J, Willemsen G, Gharib SA, Zgaga L, Mihailov E, Stone KL, Campbell H, Brouwer RWW, Demirkan A, Isaacs A, Dogas Z, Marciante KD, Campbell S, Borovecki F, Luik AI, Li M, Hottenga JJ, Huffman JE, van den Hout MCGN, Cummings SR, Aulchenko YS, Gehrman PR, Uitterlinden AG, Wichmann HE, Müller-Nurasyid M, Fehrmann RSN, Montgomery GW, Hofman A, Kao WHL, Oostra BA, Wright AF, Vink JM, Wilson JF, Pramstaller PP, Hicks AA, Polasek O, Punjabi NM, Redline S, Psaty BM, Heath AC, Merrow M, Tranah GJ, Gottlieb DJ, Boomsma DI, Martin NG, Rudan I, Tiemeier H, van IJcken WFJ, Penninx BW, Metspalu A, Meitinger T, Franke L, Roenneberg T, van Duijn CM. Genetic variants in RBFOX3 are associated with sleep latency. Eur J Hum Genet 2016; 24:1488-95. [PMID: 27142678 PMCID: PMC5027680 DOI: 10.1038/ejhg.2016.31] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Revised: 01/13/2016] [Accepted: 02/01/2016] [Indexed: 01/30/2023] Open
Abstract
Time to fall asleep (sleep latency) is a major determinant of sleep quality. Chronic, long sleep latency is a major characteristic of sleep-onset insomnia and/or delayed sleep phase syndrome. In this study we aimed to discover common polymorphisms that contribute to the genetics of sleep latency. We performed a meta-analysis of genome-wide association studies (GWAS) including 2 572 737 single nucleotide polymorphisms (SNPs) established in seven European cohorts including 4242 individuals. We found a cluster of three highly correlated variants (rs9900428, rs9907432 and rs7211029) in the RNA-binding protein fox-1 homolog 3 gene (RBFOX3) associated with sleep latency (P-values=5.77 × 10(-08), 6.59 × 10(-)(08) and 9.17 × 10(-)(08)). These SNPs were replicated in up to 12 independent populations including 30 377 individuals (P-values=1.5 × 10(-)(02), 7.0 × 10(-)(03) and 2.5 × 10(-)(03); combined meta-analysis P-values=5.5 × 10(-07), 5.4 × 10(-07) and 1.0 × 10(-07)). A functional prediction of RBFOX3 based on co-expression with other genes shows that this gene is predominantly expressed in brain (P-value=1.4 × 10(-316)) and the central nervous system (P-value=7.5 × 10(-)(321)). The predicted function of RBFOX3 based on co-expression analysis with other genes shows that this gene is significantly involved in the release cycle of neurotransmitters including gamma-aminobutyric acid and various monoamines (P-values<2.9 × 10(-11)) that are crucial in triggering the onset of sleep. To conclude, in this first large-scale GWAS of sleep latency we report a novel association of variants in RBFOX3 gene. Further, a functional prediction of RBFOX3 supports the involvement of RBFOX3 with sleep latency.
Collapse
Affiliation(s)
- Najaf Amin
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Karla V Allebrandt
- Institute of Medical Psychology, Ludwig-Maximilians-University, Munich, Germany
| | - Ashley van der Spek
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | | | - Karin Hek
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Maris Teder-Laving
- Estonian Genome Center, University of Tartu and Estonian Biocenter, Tartu, Estonia
| | - Caroline Hayward
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu and Estonian Biocenter, Tartu, Estonia
| | - Josine G van Mill
- Department of Psychiatry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
| | - Hamdi Mbarek
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Nathaniel F Watson
- Department of Neurology, University of Washington, Seattle, WA, USA
- University of Washington Medicine Sleep Center, Seattle, WA, USA
| | - Scott A Melville
- Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA
| | - Fabiola M Del Greco
- Center for Biomedicine, European Academy of Bolzano, Bolzano, Italy - Affiliated Institute of the University of Lübeck, Lübeck, Germany
| | - Enda M Byrne
- Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia
- Queensland Institute of Medical Research, Brisbane, QLD, Australia
| | - Edwin Oole
- Center for Biomics, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Ivana Kolcic
- School of Medicine, University of Split, Split, Croatia
| | - Ting-hsu Chen
- VA Boston Healthcare System, Boston University, Boston, MA, USA
| | - Daniel S Evans
- California Pacific Medical Center Research Institute, San Francisco, CA, USA
| | - Josef Coresh
- Departments of Epidemiology, Biostatistics, and Medicine, Johns Hopkins University, Baltimore, MD, USA
| | - Nicole Vogelzangs
- Department of Psychiatry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
| | - Juha Karjalainen
- Department of Genetics, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
| | - Gonneke Willemsen
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Sina A Gharib
- University of Washington Medicine Sleep Center, Seattle, WA, USA
- Department of Medicine, Division of Pulmonary & Critical Care Medicine, University of Washington, Seattle, WA, USA
| | - Lina Zgaga
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
| | - Evelin Mihailov
- Estonian Genome Center, University of Tartu and Estonian Biocenter, Tartu, Estonia
| | - Katie L Stone
- California Pacific Medical Center Research Institute, San Francisco, CA, USA
| | - Harry Campbell
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Rutger WW Brouwer
- Center for Biomics, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Ayse Demirkan
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Aaron Isaacs
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Zoran Dogas
- Department of Neuroscience and Sleep Medicine Centre, University of Split School of Medicine, Split, Croatia
| | - Kristin D Marciante
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
| | - Susan Campbell
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
| | - Fran Borovecki
- Centre for Functional Genomics and Department of Neurology, Faculty of Medicine, University of Zagreb, Zagreb, Croatia
| | - Annemarie I Luik
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Man Li
- Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
| | - Jouke Jan Hottenga
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Jennifer E Huffman
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
| | | | - Steven R Cummings
- California Pacific Medical Center Research Institute, San Francisco, CA, USA
| | - Yurii S Aulchenko
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Philip R Gehrman
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium for Healthy Ageing and National Genomics Initiative, Leiden, The Netherlands
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Zentrum Munich-German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University and Klinikum Grosshadern, Munich, Germany
- Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany
| | - Martina Müller-Nurasyid
- Institute of Epidemiology I, Helmholtz Zentrum Munich-German Research Center for Environmental Health, Neuherberg, Germany
- Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Rudolf SN Fehrmann
- Department of Genetics, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
| | | | - Albert Hofman
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Wen Hong Linda Kao
- Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
| | - Ben A Oostra
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Alan F Wright
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
| | - Jacqueline M Vink
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - James F Wilson
- Medical Research Council, Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, Scotland
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Peter P Pramstaller
- Center for Biomedicine, European Academy of Bolzano, Bolzano, Italy - Affiliated Institute of the University of Lübeck, Lübeck, Germany
- Department of Neurology, General Central Hospital, Bolzano, Italy
- Department of Neurology, University of Lübeck, Lübeck, Germany
| | - Andrew A Hicks
- Center for Biomedicine, European Academy of Bolzano, Bolzano, Italy - Affiliated Institute of the University of Lübeck, Lübeck, Germany
| | - Ozren Polasek
- School of Medicine, University of Split, Split, Croatia
- Centre for Global Health, University of Split School of Medicine, Split, Croatia
| | - Naresh M Punjabi
- Department of Pulmonary Medicine and Epidemiology, Johns Hopkins University, Baltimore, MD, USA
| | - Susan Redline
- Department of Medicine, Brigham and Women's Hospital and Beth Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Bruce M Psaty
- Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology and Health Services, University of Washington, Seattle, WA, USA
- Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA
| | - Andrew C Heath
- Department of Psychiatry, Washington University, St Louis, MO, USA
| | - Martha Merrow
- Institute of Medical Psychology, Ludwig-Maximilians-University, Munich, Germany
| | - Gregory J Tranah
- California Pacific Medical Center Research Institute, San Francisco, CA, USA
| | - Daniel J Gottlieb
- Department of Medicine, Brigham and Women's Hospital and Beth Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
- VA Boston Healthcare System, Boston, MA, USA
| | - Dorret I Boomsma
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | | | - Igor Rudan
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands
- Department of Child and Adolescent Psychiatry, Erasmus MC, Rotterdam, The Netherlands
| | | | - Brenda W Penninx
- Department of Psychiatry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu and Estonian Biocenter, Tartu, Estonia
| | - Thomas Meitinger
- Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany
- Institute of Human Genetics, Techinsche Universität München, München, Germany
| | - Lude Franke
- Department of Genetics, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
| | - Till Roenneberg
- Institute of Medical Psychology, Ludwig-Maximilians-University, Munich, Germany
| | - Cornelia M van Duijn
- Unit of Genetic Epidemiology, Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
- Netherlands Consortium for Healthy Ageing and National Genomics Initiative, Leiden, The Netherlands
- Centre for Medical Systems Biology, Leiden, The Netherlands
| |
Collapse
|
23
|
Bigert C, Gustavsson P, Straif K, Taeger D, Pesch B, Kendzia B, Schüz J, Stücker I, Guida F, Brüske I, Wichmann HE, Pesatori AC, Landi MT, Caporaso N, Tse LA, Yu ITS, Siemiatycki J, Lavoué J, Richardi L, Mirabelli D, Simonato L, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Field JK, Mannetje A, Pearce N, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Boffetta P, Peters S, Vermeulen R, Kromhout H, Brüning T, Olsson AC. P025 Lung cancer risk among firefighters when accounting for tobacco smoking – preliminary results from a pooled analysis of case-control studies from europe, canada, new zealand and china. Cancer 2016. [DOI: 10.1136/oemed-2016-103951.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Behrens T, Groß I, Siemiatycki J, Conway DI, Olsson A, Stücker I, Guida F, Jöckel KH, Pohlabeln H, Ahrens W, Brüske I, Wichmann HE, Gustavsson P, Consonni D, Merletti F, Richiardi L, Simonato L, Fortes C, Parent ME, McLaughlin J, Demers P, Landi MT, Caporaso N, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Tardón A, Field JK, Dumitru RS, Bencko V, Foretova L, Janout V, Kromhout H, Vermeulen R, Boffetta P, Straif K, Schüz J, Hovanec J, Kendzia B, Pesch B, Brüning T. Occupational prestige, social mobility and the association with lung cancer in men. BMC Cancer 2016; 16:395. [PMID: 27388894 PMCID: PMC4936282 DOI: 10.1186/s12885-016-2432-9] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2015] [Accepted: 06/10/2016] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND The nature of the association between occupational social prestige, social mobility, and risk of lung cancer remains uncertain. Using data from the international pooled SYNERGY case-control study, we studied the association between lung cancer and the level of time-weighted average occupational social prestige as well as its lifetime trajectory. METHODS We included 11,433 male cases and 14,147 male control subjects. Each job was translated into an occupational social prestige score by applying Treiman's Standard International Occupational Prestige Scale (SIOPS). SIOPS scores were categorized as low, medium, and high prestige (reference). We calculated odds ratios (OR) with 95 % confidence intervals (CI), adjusting for study center, age, smoking, ever employment in a job with known lung carcinogen exposure, and education. Trajectories in SIOPS categories from first to last and first to longest job were defined as consistent, downward, or upward. We conducted several subgroup and sensitivity analyses to assess the robustness of our results. RESULTS We observed increased lung cancer risk estimates for men with medium (OR = 1.23; 95 % CI 1.13-1.33) and low occupational prestige (OR = 1.44; 95 % CI 1.32-1.57). Although adjustment for smoking and education reduced the associations between occupational prestige and lung cancer, they did not explain the association entirely. Traditional occupational exposures reduced the associations only slightly. We observed small associations with downward prestige trajectories, with ORs of 1.13, 95 % CI 0.88-1.46 for high to low, and 1.24; 95 % CI 1.08-1.41 for medium to low trajectories. CONCLUSIONS Our results indicate that occupational prestige is independently associated with lung cancer among men.
Collapse
Affiliation(s)
- Thomas Behrens
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Isabelle Groß
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Jack Siemiatycki
- />Hospital Research Center (CRCHUM) and School of Public Health, University of Montreal, Montreal, Canada
| | - David I. Conway
- />Dental School, College of Medicine Veterinary and Life Sciences, University of Glasgow, Glasgow, G2 3JZ UK
| | - Ann Olsson
- />International Agency for Research on Cancer (IARC), Lyon, France
- />Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Isabelle Stücker
- />Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, F-94807 Villejuif, France
- />University Paris-Sud, UMRS 1018, F-94807 Villejuif, France
| | - Florence Guida
- />Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, F-94807 Villejuif, France
- />University Paris-Sud, UMRS 1018, F-94807 Villejuif, France
| | - Karl-Heinz Jöckel
- />Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
| | - Hermann Pohlabeln
- />Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany
| | - Wolfgang Ahrens
- />Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany
- />Institute for Statistics, University Bremen, Bremen, Germany
| | - Irene Brüske
- />Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- />Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany
- />Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany
| | - Per Gustavsson
- />Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Dario Consonni
- />Unit of Epidemiology, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Milan, Italy
| | - Franco Merletti
- />Department of Medical Sciences, Unit of Cancer Epidemiology, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- />Department of Medical Sciences, Unit of Cancer Epidemiology, University of Turin, Turin, Italy
| | - Lorenzo Simonato
- />Department of Molecular Medicine, Laboratory of Public Health and Population Studies, University of Padova, Padova, Italy
| | - Cristina Fortes
- />Epidemiology Unit, Istituto Dermopatico dell’Immacolata, Rome, Italy
| | - Marie-Elise Parent
- />INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec Canada
| | - John McLaughlin
- />Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada
| | - Paul Demers
- />Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada
| | - Maria Teresa Landi
- />National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, USA
| | - Neil Caporaso
- />National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, USA
| | - David Zaridze
- />Institute of Carcinogenesis, Russian Cancer Research Centre, Moscow, Russia
| | | | - Peter Rudnai
- />National Centre for Public Health, Budapest, Hungary
| | - Jolanta Lissowska
- />The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland
| | - Eleonora Fabianova
- />Regional Authority of Public Health, Preventive Occupational Medicine, Banska Bystrica, Slovakia
| | - Adonina Tardón
- />Molecular Epidemiology of Cancer Unit, University of Oviedo-Ciber de Epidemiologia, CIBERESP, Oviedo, Spain
| | - John K. Field
- />Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Liverpool, UK
- />Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | | | - Vladimir Bencko
- />Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Lenka Foretova
- />Department of Cancer Epidemiology & Genetics, Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Brno, Czech Republic
| | - Vladimir Janout
- />Faculty of Medicine, Palacky University, Olomouc, Czech Republic
- />Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
| | - Hans Kromhout
- />Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Roel Vermeulen
- />Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Paolo Boffetta
- />The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Kurt Straif
- />International Agency for Research on Cancer (IARC), Lyon, France
| | - Joachim Schüz
- />International Agency for Research on Cancer (IARC), Lyon, France
| | - Jan Hovanec
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Benjamin Kendzia
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Beate Pesch
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Thomas Brüning
- />Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| |
Collapse
|
25
|
Kilpeläinen TO, Carli JFM, Skowronski AA, Sun Q, Kriebel J, Feitosa MF, Hedman ÅK, Drong AW, Hayes JE, Zhao J, Pers TH, Schick U, Grarup N, Kutalik Z, Trompet S, Mangino M, Kristiansson K, Beekman M, Lyytikäinen LP, Eriksson J, Henneman P, Lahti J, Tanaka T, Luan J, Del Greco M F, Pasko D, Renström F, Willems SM, Mahajan A, Rose LM, Guo X, Liu Y, Kleber ME, Pérusse L, Gaunt T, Ahluwalia TS, Ju Sung Y, Ramos YF, Amin N, Amuzu A, Barroso I, Bellis C, Blangero J, Buckley BM, Böhringer S, I Chen YD, de Craen AJN, Crosslin DR, Dale CE, Dastani Z, Day FR, Deelen J, Delgado GE, Demirkan A, Finucane FM, Ford I, Garcia ME, Gieger C, Gustafsson S, Hallmans G, Hankinson SE, Havulinna AS, Herder C, Hernandez D, Hicks AA, Hunter DJ, Illig T, Ingelsson E, Ioan-Facsinay A, Jansson JO, Jenny NS, Jørgensen ME, Jørgensen T, Karlsson M, Koenig W, Kraft P, Kwekkeboom J, Laatikainen T, Ladwig KH, LeDuc CA, Lowe G, Lu Y, Marques-Vidal P, Meisinger C, Menni C, Morris AP, Myers RH, Männistö S, Nalls MA, Paternoster L, Peters A, Pradhan AD, Rankinen T, Rasmussen-Torvik LJ, Rathmann W, Rice TK, Brent Richards J, Ridker PM, Sattar N, Savage DB, Söderberg S, Timpson NJ, Vandenput L, van Heemst D, Uh HW, Vohl MC, Walker M, Wichmann HE, Widén E, Wood AR, Yao J, Zeller T, Zhang Y, Meulenbelt I, Kloppenburg M, Astrup A, Sørensen TIA, Sarzynski MA, Rao DC, Jousilahti P, Vartiainen E, Hofman A, Rivadeneira F, Uitterlinden AG, Kajantie E, Osmond C, Palotie A, Eriksson JG, Heliövaara M, Knekt PB, Koskinen S, Jula A, Perola M, Huupponen RK, Viikari JS, Kähönen M, Lehtimäki T, Raitakari OT, Mellström D, Lorentzon M, Casas JP, Bandinelli S, März W, Isaacs A, van Dijk KW, van Duijn CM, Harris TB, Bouchard C, Allison MA, Chasman DI, Ohlsson C, Lind L, Scott RA, Langenberg C, Wareham NJ, Ferrucci L, Frayling TM, Pramstaller PP, Borecki IB, Waterworth DM, Bergmann S, Waeber G, Vollenweider P, Vestergaard H, Hansen T, Pedersen O, Hu FB, Eline Slagboom P, Grallert H, Spector TD, Jukema JW, Klein RJ, Schadt EE, Franks PW, Lindgren CM, Leibel RL, Loos RJF. Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun 2016; 7:10494. [PMID: 26833098 PMCID: PMC4740377 DOI: 10.1038/ncomms10494] [Citation(s) in RCA: 129] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Accepted: 12/16/2015] [Indexed: 01/20/2023] Open
Abstract
Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10(-6) in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10(-8)) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.
Collapse
Affiliation(s)
- Tuomas O Kilpeläinen
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.,Genetics of Obesity and Related Metabolic Traits Program, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Jayne F Martin Carli
- Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York 10032, USA
| | - Alicja A Skowronski
- Institute of Human Nutrition, Columbia University, New York, New York 10032, USA
| | - Qi Sun
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachussetts 02115, USA.,Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachussetts 02115, USA
| | - Jennifer Kriebel
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,German Center for Diabetes Research (DZD), München-Neuherberg 85764, Germany
| | - Mary F Feitosa
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - Åsa K Hedman
- Science for Life Laboratory, Uppsala University, Uppsala 750 85, Sweden.,Department of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala 751 85, Sweden.,Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
| | - Alexander W Drong
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
| | - James E Hayes
- Cell and Developmental Biology Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, New York 10021, USA.,Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Jinghua Zhao
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Tune H Pers
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachussetts 02115, USA.,Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 2142, USA.,Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.,Department of Epidemiology Research, Statens Serum Institut, Copenhagen 2300, Denmark
| | - Ursula Schick
- Genetics of Obesity and Related Metabolic Traits Program, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Niels Grarup
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark
| | - Zoltán Kutalik
- Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne 1010, Switzerland.,Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland
| | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden 2333, The Netherlands.,Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK.,National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' Foundation Trust, London SE1 9RT, UK
| | - Kati Kristiansson
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland.,Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland
| | - Marian Beekman
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, Fimlab Laboratories, Tampere FI-33101, Finland.,Department of Clinical Chemistry, University of Tampere School of Medicine, Tampere FI-33014, Finland
| | - Joel Eriksson
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden
| | - Peter Henneman
- Department of Human Genetics, Leiden University Medical Center, Leiden 2333, The Netherlands.,Department of Clinical Genetics, Amsterdam Medical Center, Amsterdam 1081 HV, The Netherlands
| | - Jari Lahti
- Institute of Behavioural Sciences, University of Helsinki, Helsinki FI-00014, Finland.,Folkhälsan Research Center, Helsinki FI-00290, Finland
| | - Toshiko Tanaka
- Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland 21225, USA
| | - Jian'an Luan
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Fabiola Del Greco M
- Center for Biomedicine, European Academy Bozen/Bolzano (EURAC) - Affiliated Institute of the University of Lübeck, Bolzano 39100, Italy
| | - Dorota Pasko
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX2 5DW, UK
| | - Frida Renström
- Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö 20502, Sweden.,Department of Biobank Research, Umeå University, Umeå 90187, Sweden
| | - Sara M Willems
- Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - Anubha Mahajan
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
| | - Lynda M Rose
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachussetts 02215, USA
| | - Xiuqing Guo
- Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Institute for Translational Genomics and Population Sciences, Torrance, California 90502, USA
| | - Yongmei Liu
- Center for Human Genetics, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA
| | - Marcus E Kleber
- Medical Faculty Mannheim, Vth Department of Medicine, Heidelberg University, Mannheim 68167, Germany
| | - Louis Pérusse
- Department of Kinesiology, Laval University, Quebec City, Quebec, Canada G1V 0A6.,Institute of Nutrition and Functional Foods, Quebec City, Quebec, Canada G1V 0A6
| | - Tom Gaunt
- MRC Integrative Epidemiology Unit and School of Social and Community Medicine, University of Bristol, Bristol BS82BN, UK
| | - Tarunveer S Ahluwalia
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Ledreborg Allé, Copenhagen DK-2820, Denmark.,Steno Diabetes Center, Gentofte DK-2820, Denmark
| | - Yun Ju Sung
- Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri 63108, USA.,Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - Yolande F Ramos
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Najaf Amin
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - Antoinette Amuzu
- Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
| | - Inês Barroso
- Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.,NIHR Cambridge Biomedical Research Centre, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.,The University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge CB2 0QQ, UK
| | - Claire Bellis
- Human Genetics, Genome Institute of Singapore, Agency for Science, Technology and Research of Singapore, Singapore 138672, Singapore.,Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland 4001, Australia.,Texas Biomedical Research Institute, San Antonio, Texas 78245, USA
| | - John Blangero
- Texas Biomedical Research Institute, San Antonio, Texas 78245, USA
| | - Brendan M Buckley
- Department of Pharmacology and Therapeutics, University College Cork, Cork T12 YT57, Ireland
| | - Stefan Böhringer
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Yii-Der I Chen
- Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Institute for Translational Genomics and Population Sciences, Torrance, California 90502, USA
| | - Anton J N de Craen
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - David R Crosslin
- Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.,Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA
| | - Caroline E Dale
- Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
| | - Zari Dastani
- Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G4
| | - Felix R Day
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Joris Deelen
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Graciela E Delgado
- Medical Faculty Mannheim, Vth Department of Medicine, Heidelberg University, Mannheim 68167, Germany
| | - Ayse Demirkan
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands.,Department of Human Genetics, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Francis M Finucane
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Ian Ford
- Robertson Center for Biostatistics, University of Glasgow, Glasgow G12 8QQ, UK
| | - Melissa E Garcia
- National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 2089, USA
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Stefan Gustafsson
- Science for Life Laboratory, Uppsala University, Uppsala 750 85, Sweden.,Department of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala 751 85, Sweden
| | - Göran Hallmans
- Department of Biobank Research, Umeå University, Umeå 90187, Sweden
| | - Susan E Hankinson
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachussetts 02115, USA.,Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts 01003, USA.,Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, USA
| | - Aki S Havulinna
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Christian Herder
- German Center for Diabetes Research (DZD), München-Neuherberg 85764, Germany.,Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf 40225, Germany
| | - Dena Hernandez
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland 20892, USA
| | - Andrew A Hicks
- Center for Biomedicine, European Academy Bozen/Bolzano (EURAC) - Affiliated Institute of the University of Lübeck, Bolzano 39100, Italy
| | - David J Hunter
- Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, USA
| | - Thomas Illig
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Hannover Unified Biobank, Hannover Medical School, Hannover 30625, Germany.,Institute for Human Genetics, Hannover Medical School, Hannover 30625, Germany
| | - Erik Ingelsson
- Science for Life Laboratory, Uppsala University, Uppsala 750 85, Sweden.,Department of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala 751 85, Sweden.,Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
| | - Andreea Ioan-Facsinay
- Department of Rheumatology, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - John-Olov Jansson
- Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41345, Sweden
| | - Nancy S Jenny
- Laboratory for Clinical Biochemistry Research, Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Colchester, Vermont 05405, USA
| | | | - Torben Jørgensen
- Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup 2600, Denmark.,Faculty of Medicine, University of Aalborg, Aalborg 9100, Denmark.,Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark
| | - Magnus Karlsson
- Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences and Orthopaedic Surgery, Lund University, Skåne University Hospital, Malmö 21428, Sweden
| | - Wolfgang Koenig
- Department of Internal Medicine II - Cardiology, University of Ulm, Ulm 89081, Germany.,Deutsches Herzzentrum München, Technische Universität München, Munich 80636, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich 80539, Germany
| | - Peter Kraft
- Department of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachussetts 02115, USA
| | - Joanneke Kwekkeboom
- Department of Rheumatology, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Tiina Laatikainen
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland.,Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio FI-70211, Finland.,Hospital District of North Karelia, Joensuu FI-80210, Finland
| | - Karl-Heinz Ladwig
- Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,Department of Psychosomatic Medicine and Psychotherapy, Klinikum Rechts der Isar, Technische Universität München, Munich 81675, Germany
| | - Charles A LeDuc
- Division of Molecular Genetics, Department of Pediatrics, Columbia University, New York, New York 10029, USA
| | - Gordon Lowe
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK
| | - Yingchang Lu
- Genetics of Obesity and Related Metabolic Traits Program, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Pedro Marques-Vidal
- Department of Internal Medicine, Lausanne University Hospital, Lausanne 1011, Switzerland
| | - Christa Meisinger
- Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,German Center for Diabetes Research (DZD), München-Neuherberg 85764, Germany
| | - Cristina Menni
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
| | - Andrew P Morris
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.,Department of Biostatistics, University of Liverpool, Liverpool L69 3GA, UK
| | - Richard H Myers
- Department of Neurology, Boston University School of Medicine, Boston, Massachussetts 02118, USA
| | - Satu Männistö
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Mike A Nalls
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland 20892, USA
| | - Lavinia Paternoster
- MRC Integrative Epidemiology Unit and School of Social and Community Medicine, University of Bristol, Bristol BS82BN, UK
| | - Annette Peters
- Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,German Center for Diabetes Research (DZD), München-Neuherberg 85764, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich 80539, Germany
| | - Aruna D Pradhan
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachussetts 02215, USA.,Harvard Medical School, Boston, Massachussetts 02115, USA
| | - Tuomo Rankinen
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, Los Angeles 70808, USA
| | | | - Wolfgang Rathmann
- Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf 40225, Germany
| | - Treva K Rice
- Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri 63108, USA.,Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - J Brent Richards
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK.,Department of Medicine, Human Genetics and Epidemiology, McGill University, Montreal, Quebec, Canada H3A 0G4
| | - Paul M Ridker
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachussetts 02215, USA.,Harvard Medical School, Boston, Massachussetts 02115, USA
| | - Naveed Sattar
- Faculty of Medicine, BHF Glasgow Cardiovascular Research Centre, Glasgow G12 8QQ, UK
| | - David B Savage
- The University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge CB2 0QQ, UK
| | - Stefan Söderberg
- Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå 90187, Sweden
| | - Nicholas J Timpson
- MRC Integrative Epidemiology Unit and School of Social and Community Medicine, University of Bristol, Bristol BS82BN, UK
| | - Liesbeth Vandenput
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden
| | - Diana van Heemst
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Hae-Won Uh
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Marie-Claude Vohl
- Institute of Nutrition and Functional Foods, Quebec City, Quebec, Canada G1V 0A6.,School of Nutrition, Laval University, Quebec City, Quebec, Canada G1V 0A6
| | - Mark Walker
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE1 7RU, UK
| | - Heinz-Erich Wichmann
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universität and Klinikum Grosshadern, Munich 80336, Germany.,Institute of Epidemiology I, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich 81675, Germany
| | - Elisabeth Widén
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland
| | - Andrew R Wood
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX2 5DW, UK
| | - Jie Yao
- Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Institute for Translational Genomics and Population Sciences, Torrance, California 90502, USA
| | - Tanja Zeller
- German Center for Cardiovascular Research (DZHK e.V.), partner site Hamburg/Kiel/Lübeck, Hamburg 20246, Germany.,Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg 20246, Germany
| | - Yiying Zhang
- Division of Molecular Genetics, Department of Pediatrics, Columbia University, New York, New York 10029, USA
| | - Ingrid Meulenbelt
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Margreet Kloppenburg
- Department of Rheumatology, Leiden University Medical Center, Leiden 2333, The Netherlands.,Department of Clinical Epidemiology, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Arne Astrup
- Faculty of Science, Department of Nutrition, Exercise, and Sports, University of Copenhagen, Copenhagen 1165, Denmark
| | - Thorkild I A Sørensen
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,MRC Integrative Epidemiology Unit and School of Social and Community Medicine, University of Bristol, Bristol BS82BN, UK.,Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals, The Capital Region, Copenhagen 2000, Denmark
| | - Mark A Sarzynski
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, Los Angeles 70808, USA
| | - D C Rao
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.,Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri 63108, USA.,Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - Pekka Jousilahti
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Erkki Vartiainen
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Albert Hofman
- Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - Fernando Rivadeneira
- Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands.,Department of Internal Medicine, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands.,Department of Internal Medicine, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - Eero Kajantie
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland.,Children's Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki FI-00014, Finland.,Department of Obstetrics and Gynaecology, MRC Oulu, Oulu University Central Hospital and University of Oulu, Oulu 90220, Finland
| | - Clive Osmond
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Aarno Palotie
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland.,Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.,Center for Human Genetic Research, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
| | - Johan G Eriksson
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland.,Folkhälsan Research Center, Helsinki FI-00290, Finland.,Department of General Practice and Primary Health Care, University of Helsinki, Helsinki FI-00014, Finland
| | - Markku Heliövaara
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Paul B Knekt
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Seppo Koskinen
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Antti Jula
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland
| | - Markus Perola
- Department of Health, National Institute for Health and Welfare, Helsinki FI-00271, Finland.,Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland.,University of Tartu, Estonian Genome Centre, Tartu 51010, Estonia
| | - Risto K Huupponen
- Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku FI-20520, Finland.,Unit of Clinical Pharmacology, Turku University Hospital, Turku FI-20520, Finland
| | - Jorma S Viikari
- Division of Medicine, Turku University Hospital, Turku FI-20520, Finland.,Department of Medicine, University of Turku, Turku FI-20520, Finland
| | - Mika Kähönen
- Department of Clinical Physiology, Tampere University Hospital, Tampere FI-33521, Finland.,Department of Clinical Physiology, University of Tampere School of Medicine, Tampere FI-33014, Finland
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Fimlab Laboratories, Tampere FI-33101, Finland.,Department of Clinical Chemistry, University of Tampere School of Medicine, Tampere FI-33014, Finland
| | - Olli T Raitakari
- Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku FI-2051, Finland.,Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku FI-20520, Finland
| | - Dan Mellström
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden
| | - Mattias Lorentzon
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden
| | - Juan P Casas
- Farr Institute of Health Informatics, University College London, London NW1 2DA, UK
| | | | - Winfried März
- Medical Faculty Mannheim, Vth Department of Medicine, Heidelberg University, Mannheim 68167, Germany.,Synlab Academy, Synlab Services LLC, Mannheim 68161, Germany.,Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz 8010, Austria
| | - Aaron Isaacs
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands
| | - Ko W van Dijk
- Department of Human Genetics, Leiden University Medical Center, Leiden 2333, The Netherlands
| | - Cornelia M van Duijn
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, The Netherlands.,Center of Medical Systems Biology, Leiden 2300 RC, The Netherlands
| | - Tamara B Harris
- Laboratory of Epidemiology and Population Science, National Institute on Aging, Bethesda, Maryland 20892, USA
| | - Claude Bouchard
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, Los Angeles 70808, USA
| | - Matthew A Allison
- Family and Preventive Medicine, University of California-San Diego, La Jolla, California 92161, USA
| | - Daniel I Chasman
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachussetts 02215, USA.,Harvard Medical School, Boston, Massachussetts 02115, USA
| | - Claes Ohlsson
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden
| | - Lars Lind
- Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala 75185, Sweden
| | - Robert A Scott
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Claudia Langenberg
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Nicholas J Wareham
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Luigi Ferrucci
- Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland 21225, USA
| | - Timothy M Frayling
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX2 5DW, UK
| | - Peter P Pramstaller
- Center for Biomedicine, European Academy Bozen/Bolzano (EURAC) - Affiliated Institute of the University of Lübeck, Bolzano 39100, Italy.,Department of Neurology, General Central Hospital, Bolzano 39100, Italy.,Department of Neurology, University of Lübeck, Lübeck 23562, Germany
| | - Ingrid B Borecki
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | | | - Sven Bergmann
- Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland.,Department of Medical Genetics, University of Lausanne, Lausanne 1015, Switzerland
| | - Gérard Waeber
- Department of Internal Medicine, Lausanne University Hospital, Lausanne 1011, Switzerland
| | - Peter Vollenweider
- Department of Internal Medicine, Lausanne University Hospital, Lausanne 1011, Switzerland
| | - Henrik Vestergaard
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,Steno Diabetes Center, Gentofte DK-2820, Denmark
| | - Torben Hansen
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark.,Faculty of Health Sciences, University of Southern Denmark, Odense 5230, Denmark
| | - Oluf Pedersen
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Copenhagen 2100, Denmark
| | - Frank B Hu
- Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, USA
| | - P Eline Slagboom
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
| | - Harald Grallert
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg 85764, Germany.,German Center for Diabetes Research (DZD), München-Neuherberg 85764, Germany
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
| | - J W Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden 2333, The Netherlands.,Interuniversity Cardiology Institute of the Netherlands, Utrecht 3511 EP, The Netherlands.,Durrer Center for Cardiogenetic Research, Amsterdam 1105 AZ, The Netherlands
| | - Robert J Klein
- Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Erik E Schadt
- Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| | - Paul W Franks
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachussetts 02115, USA.,Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö 20502, Sweden.,Department of Public Health and Clinical Medicine, Umeå University, Umeå 90187, Sweden
| | - Cecilia M Lindgren
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.,Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachussetts 02142, USA.,The Big Data Institute, University of Oxford, Oxford OX1 2JD, UK
| | - Rudolph L Leibel
- Division of Molecular Genetics, Department of Pediatrics, Columbia University, New York, New York 10029, USA
| | - Ruth J F Loos
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.,Genetics of Obesity and Related Metabolic Traits Program, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.,The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
| |
Collapse
|
26
|
Kinnersley B, Labussière M, Holroyd A, Di Stefano AL, Broderick P, Vijayakrishnan J, Mokhtari K, Delattre JY, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Schreiber S, Wichmann HE, Nöthen MM, Swerdlow A, Lathrop M, Simon M, Bondy M, Sanson M, Houlston RS. Genome-wide association study identifies multiple susceptibility loci for glioma. Nat Commun 2015; 6:8559. [PMID: 26424050 PMCID: PMC4600760 DOI: 10.1038/ncomms9559] [Citation(s) in RCA: 88] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Accepted: 09/04/2015] [Indexed: 12/25/2022] Open
Abstract
Previous genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of glioma. To identify new glioma susceptibility loci, we conducted a meta-analysis of four GWAS (totalling 4,147 cases and 7,435 controls), with imputation using 1000 Genomes and UK10K Project data as reference. After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10(-9)) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10(-8)), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10(-11)), 12q21.2 (rs12230172, P=7.53 × 10(-11)) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10(-9)). Our findings provide further insights into the genetic basis of the different glioma subtypes.
Collapse
Affiliation(s)
- Ben Kinnersley
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| | - Marianne Labussière
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013 Paris, France
| | - Amy Holroyd
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| | - Anna-Luisa Di Stefano
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013 Paris, France
- Onconeurotek, F-75013 Paris, France
- AP-HP, GH Pitié-Salpêtrière, Service de Neurologie 2, F-75013 Paris, France
| | - Peter Broderick
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| | - Jayaram Vijayakrishnan
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| | - Karima Mokhtari
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013 Paris, France
- Onconeurotek, F-75013 Paris, France
- AP-HP, GH Pitié-Salpêtrière, Laboratoire de neuropathologie R Escourolle, F-75013 Paris, France
| | - Jean-Yves Delattre
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013 Paris, France
- Onconeurotek, F-75013 Paris, France
- AP-HP, GH Pitié-Salpêtrière, Service de Neurologie 2, F-75013 Paris, France
| | - Konstantinos Gousias
- Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
| | - Johannes Schramm
- Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
| | - Minouk J. Schoemaker
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| | - Sarah J. Fleming
- Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK
| | - Stefan Herms
- Department of Biomedicine, Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland
| | - Stefanie Heilmann
- Department of Biomedicine, Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Stefan Schreiber
- 1st Medical Department, University Clinic Schleswig-Holstein, Campus Kiel, House 6, Arnold-Heller-Straße 3, Kiel 24105, Germany
- Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, 81377 Munich, Germany
| | - Markus M. Nöthen
- Department of Biomedicine, Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Anthony Swerdlow
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
- Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK
| | - Mark Lathrop
- AP-HP, GH Pitié-Salpêtrière, Laboratoire de neuropathologie R Escourolle, F-75013 Paris, France
- Foundation Jean Dausset-CEPH, 27 Rue Juliette Dodu, 75010 Paris, France
- Génome Québec, Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G1
| | - Matthias Simon
- Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
| | - Melissa Bondy
- Division of Hematology-Oncology, Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
| | - Marc Sanson
- Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013 Paris, France
- Onconeurotek, F-75013 Paris, France
- AP-HP, GH Pitié-Salpêtrière, Service de Neurologie 2, F-75013 Paris, France
| | - Richard S. Houlston
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK
| |
Collapse
|
27
|
Taeger D, Pesch B, Kendzia B, Behrens T, Jöckel KH, Dahmann D, Siemiatycki J, Kromhout H, Vermeulen R, Peters S, Olsson A, Brüske I, Wichmann HE, Stücker I, Guida F, Tardón A, Merletti F, Mirabelli D, Richiardi L, Pohlabeln H, Ahrens W, Landi MT, Caporaso N, Pesatori AC, Mukeriya A, Szeszenia-Dabrowska N, Lissowska J, Gustavsson P, Field J, Marcus MW, Fabianova E, 't Mannetje A, Pearce N, Rudnai P, Bencko V, Janout V, Dumitru RS, Foretova L, Forastiere F, McLaughlin J, Paul Demers PD, Bueno-de-Mesquita B, Schüz J, Straif K, Brüning T. Lung cancer among coal miners, ore miners and quarrymen: smoking-adjusted risk estimates from the synergy pooled analysis of case-control studies. Scand J Work Environ Health 2015; 41:467-77. [PMID: 26153779 PMCID: PMC7334050 DOI: 10.5271/sjweh.3513] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
OBJECTIVES Working in mines and quarries has been associated with an elevated lung cancer risk but with inconsistent results for coal miners. This study aimed to estimate the smoking-adjusted lung cancer risk among coal miners and compare the risk pattern with lung cancer risks among ore miners and quarrymen. METHODS We estimated lung cancer risks of coal and ore miners and quarrymen among 14 251 lung cancer cases and 17 267 controls from the SYNERGY pooled case-control study, controlling for smoking and employment in other at-risk occupations. RESULTS Ever working as miner or quarryman (690 cases, 436 controls) was associated with an elevated odds ratio (OR) of 1.55 [95% confidence interval (95% CI) 1.34-1.79] for lung cancer. Ore miners (53 cases, 24 controls) had a higher OR (2.34, 95% CI 1.36-4.03) than quarrymen (67 cases, 39 controls; OR 1.92, 95% CI 1.21-3.05) and coal miners (442 cases, 297 controls; OR 1.40, 95% CI 1.18-1.67), but CI overlapped. We did not observe trends by duration of exposure or time since last exposure. CONCLUSIONS This pooled analysis of population-based studies demonstrated an excess lung cancer risk among miners and quarrymen that remained increased after adjustment for detailed smoking history and working in other at-risk occupations. The increase in risk among coal miners were less pronounced than for ore miners or quarrymen.
Collapse
Affiliation(s)
- Dirk Taeger
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA). Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Kühn A, Nieters A, Köttgen A, Goek ON, Michels K, Nöthlings U, Jacobs G, Meisinger C, Pessler F, Akmatov MF, Kühnisch J, Moebus S, Glocker E, Naus S, Keimling M, Leitzmann M, Linseisen J, Sarioglu H, von Toerne C, Hauck SM, Wallaschofski H, Wichmann HE, Illig T. Feasibility and quality development of biomaterials in the pretest studies of the German National Cohort. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015; 57:1255-63. [PMID: 25293886 DOI: 10.1007/s00103-014-2048-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND The German National Cohort (GNC) is designed to address research questions concerning a wide range of possible causes of major chronic diseases (e.g. cancer, diabetes, infectious, allergic, neurologic and cardiovascular diseases) as well as to identify risk factors and prognostic biomarkers for early diagnosis and prevention of these diseases. The collection of biomaterials in combination with extensive information from questionnaires and medical examinations represents one of the central study components. OBJECTIVES In two pretest studies of the German National Cohort conducted between 2011 and 2013, a range of biomaterials from a defined number of participants was collected. Ten study centres were involved in pretest 1 and 18 study centres were involved in pretest 2. Standard operation procedures (SOP) were developed and evaluated to minimize pre-analytical artefacts during biosample collection. Within the pretest studies different aspects concerning feasibility of sample collection/preparation [pretest 1 (a)] and quality control of biomarkers and proteome analyses were investigated [pretest 1 (b), (c)]. Additionally, recruitment of study participants for specific projects and examination procedures of all study centres in a defined time period according to common standards as well as transportation and decentralized storage of biological samples were tested (pretest 2). These analyses will serve as the basis for the biomaterial collection in the main study of the GNC starting in 2014. MATERIALS AND METHODS Participants, randomly chosen from the population (n = 1000 subjects recruited at ten study sites in pretest 1) were asked to donate blood, urine, saliva and stool samples. Additionally, nasal and oropharyngeal swabs were collected at the study sites and nasal swabs were collected by the participants at home. SOPs for sample collection, preparation, storage and transportation were developed and adopted for pretest 2. In pretest 2, 18 study sites (n = 599 subjects) collected biomaterials mostly identical to pretest 1. Biomarker analyses to test the quality of the biomaterials were performed. RESULTS In pretest 1 and 2, it was feasible to collect all biomaterials from nearly all invited participants without major problems. The mean response rate of the subjects was 95 %. As one important result we found for example that after blood draw the cellular fraction should be separated from the plasma and serum fractions during the first hour with no significant variation for up to 6 h at 4 ℃ for all analysed biomarkers. Moreover, quality control of samples using a proteomics approach showed no significant clustering of proteins according to different storage conditions. All developed SOPs were validated for use in the main study after some adaptation and modification. Additionally, electronic and paper documentation sheets were developed and tested to record time stamps, volumes, freezing times, and aliquot numbers of the collected biomaterials. DISCUSSION The collection of the biomaterials was feasible without major problems at all participating study sites. However, the processing times were in some cases too long. To avoid pre-analytical artefacts in sample collection, appropriate standardisation among the study sites is necessary. To achieve this, blood and urine collection will have to be adapted to specific conditions of usage of liquid handling robots, which will be available at all participating study centres in the main study of the GNC. Strict compliance with the SOPs, thorough training of the staff and accurate documentation are mandatory to obtain high sample quality for later analyses. The so obtained biomaterials represent a valuable resource for research on infectious and other common complex diseases in the GNC.
Collapse
Affiliation(s)
- A Kühn
- Helmholtz Zentrum Muenchen-German Research Center for Environmental Health (GmbH), Institute of Epidemiology I, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Bamberg F, Kauczor HU, Weckbach S, Schlett CL, Forsting M, Ladd SC, Greiser KH, Weber MA, Schulz-Menger J, Niendorf T, Pischon T, Caspers S, Amunts K, Berger K, Bülow R, Hosten N, Hegenscheid K, Kröncke T, Linseisen J, Günther M, Hirsch JG, Köhn A, Hendel T, Wichmann HE, Schmidt B, Jöckel KH, Hoffmann W, Kaaks R, Reiser MF, Völzke H. Whole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background. Radiology 2015; 277:206-20. [PMID: 25989618 DOI: 10.1148/radiol.2015142272] [Citation(s) in RCA: 105] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
PURPOSE To detail the rationale, design, and future perspective of implementing whole-body magnetic resonance (MR) imaging in the German National Cohort, a large multicentric population-based study. MATERIALS AND METHODS All institutional review boards approved the study, and informed consent is obtained before study enrollment. Participants are enrolled from a random sample of the general population at five dedicated imaging sites among 18 recruitment centers. MR imaging facilities are equipped with identical 3.0-T imager technology and use uniform MR protocols. Imager-specific hardware and software settings remained constant over the study period. On-site and centralized measures of image quality enable monitoring of completeness of the acquisitions and quality of each of the MR sequences. Certified radiologists read all MR imaging studies for presence of incidental findings according to predefined algorithms. RESULTS Over a 4-year period, six participants per day are examined at each center, totaling a final imaging cohort of approximately 30 000 participants. The MR imaging protocol is identical for each site and comprises a set of 12 native series to cover neurologic, cardiovascular, thoracoabdominal, and musculoskeletal imaging phenotypes totaling approximately 1 hour of imaging time. A dedicated analysis platform as part of a central imaging core incorporates a thin client-based integrative and modular data handling platform to enable multicentric off-site image reading for incidental findings. Scientific analysis will be pursued on a per-project hypothesis-driven basis. CONCLUSION Population-based whole-body MR imaging as part of the German National Cohort will serve to compile a comprehensive image repository, will provide insight into physiologic variants and subclinical disease burden, and has the potential to enable identification of novel imaging biomarkers of risk.
Collapse
Affiliation(s)
- Fabian Bamberg
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Hans-Ulrich Kauczor
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Sabine Weckbach
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Christopher L Schlett
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Michael Forsting
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Susanne C Ladd
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Karin Halina Greiser
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Marc-André Weber
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Jeanette Schulz-Menger
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Thoralf Niendorf
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Tobias Pischon
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Svenja Caspers
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Katrin Amunts
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Klaus Berger
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Robin Bülow
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Norbert Hosten
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Katrin Hegenscheid
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Thomas Kröncke
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Jakob Linseisen
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Matthias Günther
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Jochen G Hirsch
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Alexander Köhn
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Thomas Hendel
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Heinz-Erich Wichmann
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Börge Schmidt
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Karl-Heinz Jöckel
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Wolfgang Hoffmann
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Rudolf Kaaks
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Maximilian F Reiser
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | - Henry Völzke
- From the German National Cohort (GNC) Consortium, Central Executive Office of the German National Cohort, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany (F.B.); Department of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany (F.B., T.H., M.F.R.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany (H.U.K., S.W., C.L.S., M.A.W.); Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany (M.F., S.C.L.); Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (K.H.G., R.K.); Charité Campus Buch, ECRC Universitätsmedizin Berlin und HELIOS Klinik Berlin-Buch, Klinik für Kardiologie und Nephrologie, Berlin, Germany (J.S.); Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany (T.N.); Epidemiology Research Group, Max-Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany (T.P.); Institute of Neuroscience and Medicine (INM-1), Jülich Research Centre, Jülich, Germany (S.C., K.A.); C. and O. Vogt Institute for Brain Research, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (K.A.); JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany (K.A.); Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany (K.B.); Department of Radiology and Neuroradiology, University Medicine Greifswald, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany (R.B., N.H., K.H.); Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Klinikum Augsburg, Augsburg, Germany (T.K.); Helmholtz Zentrum München-German Research Center for Environmental Health, Munich, Germany (J.L., H.E.W.); Institute of Medical Infor
| | | |
Collapse
|
30
|
Bigert C, Gustavsson P, Straif K, Pesch B, Brüning T, Kendzia B, Schüz J, Stücker I, Guida F, Brüske I, Wichmann HE, Pesatori AC, Landi MT, Caporaso N, Tse LA, Yu ITS, Siemiatycki J, Pintos J, Merletti F, Mirabelli D, Simonato L, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Field J, 't Mannetje A, Pearce N, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Boffetta P, Forastiere F, Bueno-de-Mesquita B, Peters S, Vermeulen R, Kromhout H, Olsson AC. Lung cancer risk among cooks when accounting for tobacco smoking: a pooled analysis of case-control studies from Europe, Canada, New Zealand, and China. J Occup Environ Med 2015; 57:202-9. [PMID: 25654522 PMCID: PMC7508228 DOI: 10.1097/jom.0000000000000337] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
OBJECTIVES To investigate the risk of lung cancer among cooks, while controlling for smoking habits. METHODS We used data from the SYNERGY project including pooled information on lifetime work histories and smoking habits from 16 case-control studies conducted in Europe, Canada, New Zealand, and China. RESULTS Before adjustment for smoking, we observed an increased risk of lung cancer in male cooks, but not in female cooks. After adjusting, there was no increased risk and no significant exposure-response relationship. Nevertheless, subgroup analyses highlighted some possible excess risks of squamous cell carcinoma and small cell carcinoma in female cooks. CONCLUSIONS There is evidence that lung cancer risks among cooks may be confounded by smoking. After adjustment, cooks did not experience an increased risk of lung cancer overall. The subgroup analyses showing some excess risks among female cooks require cautious interpretation.
Collapse
Affiliation(s)
- Carolina Bigert
- From the Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardón), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellingt
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Consonni D, Matteis SD, Pesatori AC, Bertazzi PA, Olsson AC, Kromhout H, Peters S, Vermeulen RCH, Pesch B, Brüning T, Kendzia B, Behrens T, Stücker I, Guida F, Wichmann HE, Brüske I, Landi MT, Caporaso NE, Gustavsson P, Plato N, Tse LA, Yu ITS, Jöckel KH, Ahrens W, Pohlabeln H, Merletti F, Richiardi L, Simonato L, Forastiere F, Siemiatycki J, Parent MÉ, Tardón A, Boffetta P, Zaridze D, Chen Y, Field JK, 't Mannetje A, Pearce N, McLaughlin J, Demers P, Lissowska J, Szeszenia-Dabrowska N, Bencko V, Foretova L, Janout V, Rudnai P, Fabiánová E, Stanescu Dumitru R, Bueno-de-Mesquita HB, Schüz J, Straif K. Lung cancer risk among bricklayers in a pooled analysis of case-control studies. Int J Cancer 2015; 136:360-71. [PMID: 24861979 PMCID: PMC4477910 DOI: 10.1002/ijc.28986] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2014] [Revised: 04/11/2014] [Accepted: 04/24/2014] [Indexed: 11/09/2022]
Abstract
Bricklayers may be exposed to several lung carcinogens, including crystalline silica and asbestos. Previous studies that analyzed lung cancer risk among these workers had several study design limitations. We examined lung cancer risk among bricklayers within SYNERGY, a large international pooled analysis of case-control studies on lung cancer and the joint effects of occupational carcinogens. For men ever employed as bricklayers we estimated odds ratios (OR) and 95% confidence intervals (CI) adjusted for study center, age, lifetime smoking history and employment in occupations with exposures to known or suspected lung carcinogens. Among 15,608 cases and 18,531 controls, there were 695 cases and 469 controls who had ever worked as bricklayers (OR: 1.47; 95% CI: 1.28-1.68). In studies using population controls the OR was 1.55 (95% CI: 1.32-1.81, 540/349 cases/controls), while it was 1.24 (95% CI: 0.93-1.64, 155/120 cases/controls) in hospital-based studies. There was a clear positive trend with length of employment (p < 0.001). The relative risk was higher for squamous (OR: 1.68, 95% CI: 1.42-1.98, 309 cases) and small cell carcinomas (OR: 1.78, 95% CI: 1.44-2.20, 140 cases), than for adenocarcinoma (OR: 1.17, 95% CI: 0.95-1.43, 150 cases) (p-homogeneity: 0.0007). ORs were still elevated after additional adjustment for education and in analyses using blue collar workers as referents. This study provided robust evidence of increased lung cancer risk in bricklayers. Although non-causal explanations cannot be completely ruled out, the association is plausible in view of the potential for exposure to several carcinogens, notably crystalline silica and to a lesser extent asbestos.
Collapse
Affiliation(s)
- Dario Consonni
- Epidemiology Unit, Fondazione IRCCS Ca' Granda—Ospedale Maggiore PoliclinicoMilan, Italy
| | - Sara De Matteis
- National Heart & Lung Institute, Respiratory Epidemiology, Occupational Medicine and Public Health, Imperial College LondonLondon, United Kingdom
- Department of Clinical Sciences and Community Health, Università degli Studi di MilanoMilan, Italy
| | - Angela C Pesatori
- Epidemiology Unit, Fondazione IRCCS Ca' Granda—Ospedale Maggiore PoliclinicoMilan, Italy
- Department of Clinical Sciences and Community Health, Università degli Studi di MilanoMilan, Italy
| | - Pier Alberto Bertazzi
- Epidemiology Unit, Fondazione IRCCS Ca' Granda—Ospedale Maggiore PoliclinicoMilan, Italy
- Department of Clinical Sciences and Community Health, Università degli Studi di MilanoMilan, Italy
| | - Ann C Olsson
- International Agency for Research on CancerLyon, France
- The Institute of Environmental Medicine, Karolinska InstitutetStockholm, Sweden
| | - Hans Kromhout
- Institute for Risk Assessment SciencesUtrecht, The Netherlands
| | - Susan Peters
- Institute for Risk Assessment SciencesUtrecht, The Netherlands
- Occupational Respiratory Epidemiology, School of Population Health, University of Western AustraliaPerth, Australia
| | | | - Beate Pesch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA)Bochum, Germany
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA)Bochum, Germany
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA)Bochum, Germany
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA)Bochum, Germany
| | - Isabelle Stücker
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer TeamVillejuif, Paris, France
- Université Paris-Sud, UMRS 1018Villejuif, Paris, France
| | - Florence Guida
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer TeamVillejuif, Paris, France
- Université Paris-Sud, UMRS 1018Villejuif, Paris, France
| | - Heinz-Erich Wichmann
- Institut für Epidemiologie I, Deutsches Forschungszentrum für Gesundheit und UmweltNeuherberg, Germany
| | - Irene Brüske
- Institut für Epidemiologie I, Deutsches Forschungszentrum für Gesundheit und UmweltNeuherberg, Germany
| | | | | | - Per Gustavsson
- The Institute of Environmental Medicine, Karolinska InstitutetStockholm, Sweden
| | - Nils Plato
- The Institute of Environmental Medicine, Karolinska InstitutetStockholm, Sweden
| | - Lap Ah Tse
- School of Public Health and Primary Care, The Chinese University of Hong KongHong Kong, China
| | - Ignatius Tak-sun Yu
- School of Public Health and Primary Care, The Chinese University of Hong KongHong Kong, China
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital, University Duisburg-EssenEssen, Germany
| | - Wolfgang Ahrens
- Leibniz-Institute for Prevention Research and Epidemiology—BIPSBremen, Germany
- Institute for Statistics, University BremenBremen, Germany
| | - Hermann Pohlabeln
- Leibniz-Institute for Prevention Research and Epidemiology—BIPSBremen, Germany
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, CPO-PiemonteTurin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, CPO-PiemonteTurin, Italy
| | - Lorenzo Simonato
- Department of Molecular Medicine, Università degli Studi di PadovaPadua, Italy
| | | | - Jack Siemiatycki
- University of Montreal Hospital Research Center (CRCHUM) and School of Public HealthMontréal, Canada
| | - Marie-Élise Parent
- Epidemiology and Biostatistics Unit, INRS-Institut Armand-FrappierLaval, Canada
| | - Adonina Tardón
- Universidad de Oviedo and Ciber de Epidemiologia y Salud Publica (CIBERESP)Oviedo, Spain
| | - Paolo Boffetta
- The Tisch Cancer Institute, Mount Sinai School of MedicineNew York, NY
- International Prevention Research InstituteLyon, France
| | | | - Ying Chen
- Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer MedicineLiverpool, United Kingdom
- Arthritis Research UK Primary Care Centre, Research Institute for Primary Care & Health Sciences, Keele UniversityStaffordshire, United Kingdom
| | - John K Field
- Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer MedicineLiverpool, United Kingdom
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey UniversityWellington, New Zealand
| | - Neil Pearce
- Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical MedicineLondon, United Kingdom
| | | | - Paul Demers
- Occupational Cancer Research Centre, Cancer Care OntarioToronto, Canada
| | - Jolanta Lissowska
- The M Sklodowska-Curie Cancer Center and Institute of OncologyWarsaw, Poland
| | | | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles UniversityPrague, Czech Republic
| | | | - Vladimir Janout
- Palacky University, Faculty of MedicineOlomouc, Czech Republic
| | - Peter Rudnai
- National Institute of Environment HealthBudapest, Hungary
| | | | | | - H B(as) Bueno-de-Mesquita
- National Institute for Public Health and the Environment (RIVM), BilthovenThe Netherlands
- Department of Gastroenterology and Hepatology, University Medical CentreUtrecht, The Netherlands
- The School of Public Health, Imperial College LondonLondon, United Kingdom
| | - Joachim Schüz
- International Agency for Research on CancerLyon, France
| | - Kurt Straif
- International Agency for Research on CancerLyon, France
| |
Collapse
|
32
|
Denholm R, Schüz J, Straif K, Stücker I, Jöckel KH, Brenner DR, De Matteis S, Boffetta P, Guida F, Brüske I, Wichmann HE, Landi MT, Caporaso N, Siemiatycki J, Ahrens W, Pohlabeln H, Zaridze D, Field JK, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Kendzia B, Peters S, Behrens T, Vermeulen R, Brüning T, Kromhout H, C. Olsson A. Is previous respiratory disease a risk factor for lung cancer? Am J Respir Crit Care Med 2014; 190:549-59. [PMID: 25054566 PMCID: PMC4214084 DOI: 10.1164/rccm.201402-0338oc] [Citation(s) in RCA: 81] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2014] [Accepted: 06/17/2014] [Indexed: 12/18/2022] Open
Abstract
RATIONALE Previous respiratory diseases have been associated with increased risk of lung cancer. Respiratory conditions often co-occur and few studies have investigated multiple conditions simultaneously. OBJECTIVES Investigate lung cancer risk associated with chronic bronchitis, emphysema, tuberculosis, pneumonia, and asthma. METHODS The SYNERGY project pooled information on previous respiratory diseases from 12,739 case subjects and 14,945 control subjects from 7 case-control studies conducted in Europe and Canada. Multivariate logistic regression models were used to investigate the relationship between individual diseases adjusting for co-occurring conditions, and patterns of respiratory disease diagnoses and lung cancer. Analyses were stratified by sex, and adjusted for age, center, ever-employed in a high-risk occupation, education, smoking status, cigarette pack-years, and time since quitting smoking. MEASUREMENTS AND MAIN RESULTS Chronic bronchitis and emphysema were positively associated with lung cancer, after accounting for other respiratory diseases and smoking (e.g., in men: odds ratio [OR], 1.33; 95% confidence interval [CI], 1.20-1.48 and OR, 1.50; 95% CI, 1.21-1.87, respectively). A positive relationship was observed between lung cancer and pneumonia diagnosed 2 years or less before lung cancer (OR, 3.31; 95% CI, 2.33-4.70 for men), but not longer. Co-occurrence of chronic bronchitis and emphysema and/or pneumonia had a stronger positive association with lung cancer than chronic bronchitis "only." Asthma had an inverse association with lung cancer, the association being stronger with an asthma diagnosis 5 years or more before lung cancer compared with shorter. CONCLUSIONS Findings from this large international case-control consortium indicate that after accounting for co-occurring respiratory diseases, chronic bronchitis and emphysema continue to have a positive association with lung cancer.
Collapse
Affiliation(s)
- Rachel Denholm
- International Agency for Research on Cancer, Lyon, France
| | - Joachim Schüz
- International Agency for Research on Cancer, Lyon, France
| | - Kurt Straif
- International Agency for Research on Cancer, Lyon, France
| | - Isabelle Stücker
- Institut National de la Santé et de la Recherche Médicale, Center for Research in Epidemiology and Population Health, U1018, Environmental Epidemiology of Cancer Team, Villejuif, France
- Université Paris-Sud, Unité Mixte de Recherche en Santé 1018, Villejuif, France
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Darren R. Brenner
- International Agency for Research on Cancer, Lyon, France
- Department of Population Health Research, Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada
| | - Sara De Matteis
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
- National Heart and Lung Institute, Respiratory Epidemiology, Occupational Medicine, and Public Health, Imperial College London, London, United Kingdom
| | - Paolo Boffetta
- Tisch Cancer Institute and Institute for Translational Epidemiology, Mount Sinai School of Medicine, New York, New York
| | - Florence Guida
- Institut National de la Santé et de la Recherche Médicale, Center for Research in Epidemiology and Population Health, U1018, Environmental Epidemiology of Cancer Team, Villejuif, France
- Université Paris-Sud, Unité Mixte de Recherche en Santé 1018, Villejuif, France
| | - Irene Brüske
- Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institut für Epidemiologie, Deutsches Forschungszentrum fur Gesundheit und Umwelt, Neuherberg, Germany
| | | | | | - Jack Siemiatycki
- University of Montreal Hospital Research Center, Montreal, Canada
| | - Wolfgang Ahrens
- Bremen Institute for Prevention Research and Social Medicine, Bremen, Germany
| | - Hermann Pohlabeln
- Bremen Institute for Prevention Research and Social Medicine, Bremen, Germany
| | | | - John K. Field
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
| | | | - Paul Demers
- Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada
| | | | - Jolanta Lissowska
- M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland
| | - Peter Rudnai
- National Institute of Environment Health, Budapest, Hungary
| | | | | | - Vladimir Bencko
- Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Vladimir Janout
- Palacky University, Faculty of Medicine, Olomouc, Czech Republic
| | - Benjamin Kendzia
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Susan Peters
- Institute for Risk Assessment Sciences, Utrecht, The Netherlands
- Occupational Respiratory Epidemiology, School of Population Health, University of Western Australia, Perth, Australia; and
| | - Thomas Behrens
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences, Utrecht, The Netherlands
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr-Universität Bochum, Bochum, Germany
| | - Hans Kromhout
- Institute for Risk Assessment Sciences, Utrecht, The Netherlands
| | - Ann C. Olsson
- International Agency for Research on Cancer, Lyon, France
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
33
|
Fensterer V, Küchenhoff H, Maier V, Wichmann HE, Breitner S, Peters A, Gu J, Cyrys J. Evaluation of the impact of low emission zone and heavy traffic ban in Munich (Germany) on the reduction of PM₁₀ in ambient air. Int J Environ Res Public Health 2014; 11:5094-112. [PMID: 24828081 PMCID: PMC4053866 DOI: 10.3390/ijerph110505094] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 05/05/2014] [Accepted: 05/05/2014] [Indexed: 11/16/2022]
Abstract
Concentrations of ambient fine particles (PM10: particles with an aerodynamic diameter ≤ 10 µm) are still exceeding current air quality standards in many European cities. In Munich (Germany), low emission zone and transit bans for heavy-duty vehicles were introduced in 2008 aiming at reduction of traffic emissions contribution to PM10. The effects of those measures on PM10 mass concentrations in Munich were investigated with a semiparametric regression model for modeling PM10 levels adjusted for time, background pollution, public holidays and wind direction. The reduction of PM10 concentration after the introduction of the measures was larger at a traffic monitoring site (13.0 %, 19.6 % in summer, and 6.8 % in winter) and smaller in urban background (4.5 %, 5.7 % in summer, and 3.2 % in winter). The effect was most pronounced on Fridays and on the weekends in summer.
Collapse
Affiliation(s)
- Veronika Fensterer
- Statistical Consulting Unit, Department of Statistics, Ludwig-Maximilians-Universität, Akademiestr. 1, Munich 80799, Germany.
| | - Helmut Küchenhoff
- Statistical Consulting Unit, Department of Statistics, Ludwig-Maximilians-Universität, Akademiestr. 1, Munich 80799, Germany.
| | - Verena Maier
- Statistical Consulting Unit, Department of Statistics, Ludwig-Maximilians-Universität, Akademiestr. 1, Munich 80799, Germany.
| | - Heinz-Erich Wichmann
- Helmholtz Zentrum München, Institute of Epidemiology I, Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
| | - Susanne Breitner
- Helmholtz Zentrum München, Institute of Epidemiology II, Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
| | - Annette Peters
- Helmholtz Zentrum München, Institute of Epidemiology II, Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
| | - Jianwei Gu
- Helmholtz Zentrum München, Institute of Epidemiology II, Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
| | - Josef Cyrys
- Helmholtz Zentrum München, Institute of Epidemiology II, Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
| |
Collapse
|
34
|
Stratmann B, Xu T, Meisinger C, Menart B, Roden M, Herder C, Grallert H, Peters A, Koenig W, Illig T, Wichmann HE, Wang-Sattler R, Rathmann W, Tschoepe D. PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort. Cardiovasc Diabetol 2014; 13:90. [PMID: 24886443 PMCID: PMC4022397 DOI: 10.1186/1475-2840-13-90] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2014] [Accepted: 04/28/2014] [Indexed: 01/15/2023] Open
Abstract
OBJECTIVE The genetic polymorphism concerning the ß3-subunit of platelet integrin receptor glycoprotein IIIa is held responsible for enhanced binding of adhesive proteins resulting in increased thrombogenic potential. Whether it is associated with mortality, HbA1c or platelet volume is tested prospectively in an epidemiological cohort. RESEARCH DESIGN AND METHODS Population-based Cooperative Health Research in the Region of Augsburg (KORA) S4-Survey (N = 4,028) was investigated for prognostic value of PLA1A2-polymorphism regarding all-cause mortality, correlation with HbA1c, and mean platelet volume. Multivariate analysis was performed to investigate association between genotype and key variables. RESULTS Prevalence of thrombogenic allele variant PLA2 was 15.0%. Multivariate analysis revealed no association between PLA1A2 polymorphism and mortality in the KORA-cohort. HbA1c was a prognostic marker of mortality in non-diabetic persons resulting in J-shaped risk curve with dip at HbA1c = 5.5% (37 mmol/mol), confirming previous findings regarding aged KORA-S4 participants (55-75 years). PLA1A2 was significantly associated with elevated HbA1c levels in diabetic patients (N = 209) and reduced mean platelet volume in general population. In non-diabetic participants (N = 3,819), carriers of PLA2 allele variant presenting with HbA1c > 5.5% (37 mmol/mol) showed higher relative risk of mortality with increasing HbA1c. CONCLUSION PLA1A2 polymorphism is associated with mortality in participants with HbA1c ranging from 5.5% (37 mmol/mol) to 6.5% (48 mmol/mol). Maintenance of euglycemic control and antiplatelet therapy are therefore regarded as effective primary prevention in this group.
Collapse
Affiliation(s)
- Bernd Stratmann
- Heart and Diabetes Center NRW, Ruhr University Bochum, Georgstr. 11, D-32545 Bad Oeynhausen, Germany
| | - Tao Xu
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
| | - Christa Meisinger
- Institute of Epidemiology II, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
| | - Barbara Menart
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany
| | - Michael Roden
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany
| | - Christian Herder
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany
| | - Harald Grallert
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
| | - Annette Peters
- Institute of Epidemiology II, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
| | - Wolfgang Koenig
- Department Internal Medicine II, University Clinic Ulm, Ulm, Germany
| | - Thomas Illig
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
- Hannover Unified Biobank, Hannover Medical School, Hannover, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany
| | - Rui Wang-Sattler
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center of Environmental Health, Neuherberg, Germany
| | - Wolfgang Rathmann
- Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany
| | - Diethelm Tschoepe
- Heart and Diabetes Center NRW, Ruhr University Bochum, Georgstr. 11, D-32545 Bad Oeynhausen, Germany
| |
Collapse
|
35
|
Knoll N, Jarick I, Volckmar AL, Klingenspor M, Illig T, Grallert H, Gieger C, Wichmann HE, Peters A, Wiegand S, Biebermann H, Fischer-Posovszky P, Wabitsch M, Völzke H, Nauck M, Teumer A, Rosskopf D, Rimmbach C, Schreiber S, Jacobs G, Lieb W, Franke A, Hebebrand J, Hinney A. Mitochondrial DNA variants in obesity. PLoS One 2014; 9:e94882. [PMID: 24788344 PMCID: PMC4008486 DOI: 10.1371/journal.pone.0094882] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2014] [Accepted: 03/19/2014] [Indexed: 12/28/2022] Open
Abstract
Heritability estimates for body mass index (BMI) variation are high. For mothers and their offspring higher BMI correlations have been described than for fathers. Variation(s) in the exclusively maternally inherited mitochondrial DNA (mtDNA) might contribute to this parental effect. Thirty-two to 40 mtDNA single nucleotide polymorphisms (SNPs) were available from genome-wide association study SNP arrays (Affymetrix 6.0). For discovery, we analyzed association in a case-control (CC) sample of 1,158 extremely obese children and adolescents and 435 lean adult controls. For independent confirmation, 7,014 population-based adults were analyzed as CC sample of n = 1,697 obese cases (BMI ≥ 30 kg/m2) and n = 2,373 normal weight and lean controls (BMI<25 kg/m2). SNPs were analyzed as single SNPs and haplogroups determined by HaploGrep. Fisher's two-sided exact test was used for association testing. Moreover, the D-loop was re-sequenced (Sanger) in 192 extremely obese children and adolescents and 192 lean adult controls. Association testing of detected variants was performed using Fisher's two-sided exact test. For discovery, nominal association with obesity was found for the frequent allele G of m.8994G/A (rs28358887, p = 0.002) located in ATP6. Haplogroup W was nominally overrepresented in the controls (p = 0.039). These findings could not be confirmed independently. For two of the 252 identified D-loop variants nominal association was detected (m.16292C/T, p = 0.007, m.16189T/C, p = 0.048). Only eight controls carried the m.16292T allele, five of whom belonged to haplogroup W that was initially enriched among these controls. m.16189T/C might create an uninterrupted poly-C tract located near a regulatory element involved in replication of mtDNA. Though follow-up of some D-loop variants still is conceivable, our hypothesis of a contribution of variation in the exclusively maternally inherited mtDNA to the observed larger correlations for BMI between mothers and their offspring could not be substantiated by the findings of the present study.
Collapse
Affiliation(s)
- Nadja Knoll
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - Ivonne Jarick
- Institute of Medical Biometry and Epidemiology, Philipps-University of Marburg, Marburg, Germany
| | - Anna-Lena Volckmar
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - Martin Klingenspor
- Molecular Nutritional Medicine, Technical University of Munich, Else Kröner-Fresenius Center, Freising-Weihenstephan, Germany
| | - Thomas Illig
- Research Unit of Molecular Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
- Hannover Unified Biobank, Hannover Medical School, Hannover, Germany
| | - Harald Grallert
- Research Unit of Molecular Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
- German Center for Diabetes Research, Neuherberg, Germany
| | - Christian Gieger
- Institute of Genetic Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany, Neuherberg, Germany
- Institute of Medical Informatics, Biometry, and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany
- Munich University Hospital, Campus Grosshadern, Munich, Germany
| | - Annette Peters
- Institute of Epidemiology II, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
| | - Susanna Wiegand
- Institute of Experimental Pediatric Endocrinology, Charité Berlin, Germany
| | - Heike Biebermann
- Institute of Experimental Pediatric Endocrinology, Charité Berlin, Germany
| | - Pamela Fischer-Posovszky
- Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine, University of Ulm University Medical Center, Ulm, Germany
| | - Martin Wabitsch
- Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine, University of Ulm University Medical Center, Ulm, Germany
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Matthias Nauck
- Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Dieter Rosskopf
- Institute for Pharmacology, University Medicine Greifswald, Greifswald, Greifswald, Germany
| | - Christian Rimmbach
- Institute for Pharmacology, University Medicine Greifswald, Greifswald, Greifswald, Germany
| | - Stefan Schreiber
- Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
| | - Gunnar Jacobs
- Institute of Epidemiology and Biobank popgen, Christian-Albrechts-University of Kiel, Kiel, Germany
| | - Wolfgang Lieb
- Institute of Epidemiology and Biobank popgen, Christian-Albrechts-University of Kiel, Kiel, Germany
| | - Andre Franke
- Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
| | - Johannes Hebebrand
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - Anke Hinney
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
- * E-mail:
| |
Collapse
|
36
|
Vlaanderen J, Portengen L, Schüz J, Olsson A, Pesch B, Kendzia B, Stücker I, Guida F, Brüske I, Wichmann HE, Consonni D, Landi MT, Caporaso N, Siemiatycki J, Merletti F, Mirabelli D, Richiardi L, Gustavsson P, Plato N, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Field JK, 't Mannetje A, Pearce N, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Stanescu Dumitru R, Bencko V, Foretova L, Janout V, Boffetta P, Forastiere F, Bueno-de-Mesquita B, Peters S, Brüning T, Kromhout H, Straif K, Vermeulen R. Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study. Am J Epidemiol 2014; 179:290-8. [PMID: 24355332 DOI: 10.1093/aje/kwt273] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The indiscriminate use of the cumulative exposure metric (the product of intensity and duration of exposure) might bias reported associations between exposure to hazardous agents and cancer risk. To assess the independent effects of duration and intensity of exposure on cancer risk, we explored effect modification of the association of cumulative exposure and cancer risk by intensity of exposure. We applied a flexible excess odds ratio model that is linear in cumulative exposure but potentially nonlinear in intensity of exposure to 15 case-control studies of cigarette smoking and lung cancer (1985-2009). Our model accommodated modification of the excess odds ratio per pack-year of cigarette smoking by time since smoking cessation among former smokers. We observed negative effect modification of the association of pack-years of cigarette smoking and lung cancer by intensity of cigarette smoke for persons who smoked more than 20-30 cigarettes per day. Patterns of effect modification were similar across individual studies and across major lung cancer subtypes. We observed strong negative effect modification by time since smoking cessation. Application of our method in this example of cigarette smoking and lung cancer demonstrated that reducing a complex exposure history to a metric such as cumulative exposure is too restrictive.
Collapse
|
37
|
Olsson AC, Xu Y, Schüz J, Vlaanderen J, Kromhout H, Vermeulen R, Peters S, Stücker I, Guida F, Brüske I, Wichmann HE, Consonni D, Landi MT, Caporaso N, Tse LA, Yu ITS, Siemiatycki J, Richardson L, Mirabelli D, Richiardi L, Simonato L, Gustavsson P, Plato N, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Marcus MW, 't Mannetje A, Pearce N, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Boffetta P, Fortes C, Bueno-de-Mesquita B, Kendzia B, Behrens T, Pesch B, Brüning T, Straif K. Lung cancer risk among hairdressers: a pooled analysis of case-control studies conducted between 1985 and 2010. Am J Epidemiol 2013; 178:1355-65. [PMID: 24068200 DOI: 10.1093/aje/kwt119] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Increased lung cancer risks among hairdressers were observed in large registry-based cohort studies from Scandinavia, but these studies could not adjust for smoking. Our objective was to evaluate the lung cancer risk among hairdressers while adjusting for smoking and other confounders in a pooled database of 16 case-control studies conducted in Europe, Canada, China, and New Zealand between 1985 and 2010 (the Pooled Analysis of Case-Control Studies on the Joint Effects of Occupational Carcinogens in the Development of Lung Cancer). Lifetime occupational and smoking information was collected through interviews with 19,369 cases of lung cancer and 23,674 matched population or hospital controls. Overall, 170 cases and 167 controls had ever worked as hairdresser or barber. The odds ratios for lung cancer in women were 1.65 (95% confidence interval (CI): 1.16, 2.35) without adjustment for smoking and 1.12 (95% CI: 0.75, 1.68) with adjustment for smoking; however, women employed before 1954 also experienced an increased lung cancer risk after adjustment for smoking (odds ratio = 2.66, 95% CI: 1.09, 6.47). The odds ratios in male hairdressers/barbers were generally not elevated, except for an increased odds ratio for adenocarcinoma in long-term barbers (odds ratio = 2.20, 95% CI: 1.02, 4.77). Our results suggest that the increased lung cancer risks among hairdressers are due to their smoking behavior; single elevated risk estimates should be interpreted with caution and need replication in other studies.
Collapse
|
38
|
Apel M, Uebe S, Bowes J, Giardina E, Korendowych E, Juneblad K, Pasutto F, Ekici AB, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Padyukov L, FitzGerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A, Hüffmeier U. Variants inRUNX3Contribute to Susceptibility to Psoriatic Arthritis, Exhibiting Further Common Ground With Ankylosing Spondylitis. ACTA ACUST UNITED AC 2013; 65:1224-31. [DOI: 10.1002/art.37885] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2012] [Accepted: 01/22/2013] [Indexed: 01/01/2023]
|
39
|
Schulz H, Flexeder C, Behr J, Holle R, Huber RM, Jörres RA, Nowak D, Peters A, Wichmann HE, Heinrich J, Karrasch S. Referenzwerte für impulsoszillometrische Parameter bei Erwachsenen: Ergebnisse der KORA F4L und KORA Age Studie. Pneumologie 2013. [DOI: 10.1055/s-0033-1334676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
40
|
Knoll N, Jarick I, Volckmar AL, Klingenspor M, Illig T, Grallert H, Gieger C, Wichmann HE, Peters A, Hebebrand J, Scherag A, Hinney A. Gene set of nuclear-encoded mitochondrial regulators is enriched for common inherited variation in obesity. PLoS One 2013; 8:e55884. [PMID: 23409076 PMCID: PMC3568071 DOI: 10.1371/journal.pone.0055884] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2012] [Accepted: 01/03/2013] [Indexed: 01/13/2023] Open
Abstract
There are hints of an altered mitochondrial function in obesity. Nuclear-encoded genes are relevant for mitochondrial function (3 gene sets of known relevant pathways: (1) 16 nuclear regulators of mitochondrial genes, (2) 91 genes for oxidative phosphorylation and (3) 966 nuclear-encoded mitochondrial genes). Gene set enrichment analysis (GSEA) showed no association with type 2 diabetes mellitus in these gene sets. Here we performed a GSEA for the same gene sets for obesity. Genome wide association study (GWAS) data from a case-control approach on 453 extremely obese children and adolescents and 435 lean adult controls were used for GSEA. For independent confirmation, we analyzed 705 obesity GWAS trios (extremely obese child and both biological parents) and a population-based GWAS sample (KORA F4, n = 1,743). A meta-analysis was performed on all three samples. In each sample, the distribution of significance levels between the respective gene set and those of all genes was compared using the leading-edge-fraction-comparison test (cut-offs between the 50th and 95th percentile of the set of all gene-wise corrected p-values) as implemented in the MAGENTA software. In the case-control sample, significant enrichment of associations with obesity was observed above the 50th percentile for the set of the 16 nuclear regulators of mitochondrial genes (pGSEA,50 = 0.0103). This finding was not confirmed in the trios (pGSEA,50 = 0.5991), but in KORA (pGSEA,50 = 0.0398). The meta-analysis again indicated a trend for enrichment (pMAGENTA,50 = 0.1052, pMAGENTA,75 = 0.0251). The GSEA revealed that weak association signals for obesity might be enriched in the gene set of 16 nuclear regulators of mitochondrial genes.
Collapse
Affiliation(s)
- Nadja Knoll
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - Ivonne Jarick
- Institute of Medical Biometry and Epidemiology, Philipps-University of Marburg, Marburg, Germany
| | - Anna-Lena Volckmar
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - Martin Klingenspor
- Molecular Nutritional Medicine, Technical University of Munich, Else Kröner-Fresenius Center, Freising-Weihenstephan, Germany
| | - Thomas Illig
- Research Unit of Molecular Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
- Hannover Unified Biobank, Hannover Medical School, Hannover, Germany
| | - Harald Grallert
- Research Unit of Molecular Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
| | - Christian Gieger
- Institute of Genetic Epidemiology, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
| | - Heinz-Erich Wichmann
- Institute of Epidemiology I, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany, Neuherberg, Germany
- Institute of Medical Informatics, Biometry, and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany
- Munich University Hospital, Campus Grosshadern, Munich, Germany
| | - Annette Peters
- Institute of Epidemiology II, Helmholtz Center Munich – German Research Center for Environmental Health, Neuherberg, Germany
| | - Johannes Hebebrand
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
| | - André Scherag
- Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
| | - Anke Hinney
- Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany
- * E-mail:
| |
Collapse
|
41
|
Volckmar AL, Bolze F, Jarick I, Knoll N, Scherag A, Reinehr T, Illig T, Grallert H, Wichmann HE, Wiegand S, Biebermann H, Krude H, Fischer-Posovszky P, Rief W, Wabitsch M, Klingenspor M, Hebebrand J, Hinney A. Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants. BMC Med Genomics 2012; 5:65. [PMID: 23270367 PMCID: PMC3544595 DOI: 10.1186/1755-8794-5-65] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2012] [Accepted: 12/20/2012] [Indexed: 12/21/2022] Open
Abstract
Background The SH2B1 gene (Src-homology 2B adaptor protein 1 gene) is a solid candidate gene for obesity. Large scale GWAS studies depicted markers in the vicinity of the gene; animal models suggest a potential relevance for human body weight regulation. Methods We performed a mutation screen for variants in the SH2B1 coding sequence in 95 extremely obese children and adolescents. Detected variants were genotyped in independent childhood and adult study groups (up to 11,406 obese or overweight individuals and 4,568 controls). Functional implications on STAT3 mediated leptin signalling of the detected variants were analyzed in vitro. Results We identified two new rare mutations and five known SNPs (rs147094247, rs7498665, rs60604881, rs62037368 and rs62037369) in SH2B1. Mutation g.9483C/T leads to a non-synonymous, non-conservative exchange in the beta (βThr656Ile) and gamma (γPro674Ser) splice variants of SH2B1. It was additionally detected in two of 11,206 (extremely) obese or overweight children, adolescents and adults, but not in 4,506 population-based normal-weight or lean controls. The non-coding mutation g.10182C/A at the 3’ end of SH2B1 was only detected in three obese individuals. For the non-synonymous SNP rs7498665 (Thr484Ala) we observed nominal over-transmission of the previously described risk allele in 705 obesity trios (nominal p = 0.009, OR = 1.23) and an increased frequency of the same allele in 359 cases compared to 429 controls (nominal p = 0.042, OR = 1.23). The obesity risk-alleles at Thr484Ala and βThr656Ile/γPro674Ser had no effect on STAT3 mediated leptin receptor signalling in splice variants β and γ. Conclusion The rare coding mutation βThr656Ile/γPro674Ser (g.9483C/T) in SH2B1 was exclusively detected in overweight or obese individuals. Functional analyzes did not reveal impairments in leptin signalling for the mutated SH2B1.
Collapse
Affiliation(s)
- Anna-Lena Volckmar
- Department of Child and Adolescent Psychiatry, University Duisburg-Essen, Virchowstr, 171, D 45147, Essen, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Steffens M, Leu C, Ruppert AK, Zara F, Striano P, Robbiano A, Capovilla G, Tinuper P, Gambardella A, Bianchi A, La Neve A, Crichiutti G, de Kovel CGF, Kasteleijn-Nolst Trenité D, de Haan GJ, Lindhout D, Gaus V, Schmitz B, Janz D, Weber YG, Becker F, Lerche H, Steinhoff BJ, Kleefuß-Lie AA, Kunz WS, Surges R, Elger CE, Muhle H, von Spiczak S, Ostertag P, Helbig I, Stephani U, Møller RS, Hjalgrim H, Dibbens LM, Bellows S, Oliver K, Mullen S, Scheffer IE, Berkovic SF, Everett KV, Gardiner MR, Marini C, Guerrini R, Lehesjoki AE, Siren A, Guipponi M, Malafosse A, Thomas P, Nabbout R, Baulac S, Leguern E, Guerrero R, Serratosa JM, Reif PS, Rosenow F, Mörzinger M, Feucht M, Zimprich F, Kapser C, Schankin CJ, Suls A, Smets K, De Jonghe P, Jordanova A, Caglayan H, Yapici Z, Yalcin DA, Baykan B, Bebek N, Ozbek U, Gieger C, Wichmann HE, Balschun T, Ellinghaus D, Franke A, Meesters C, Becker T, Wienker TF, Hempelmann A, Schulz H, Rüschendorf F, Leber M, Pauck SM, Trucks H, Toliat MR, Nürnberg P, Avanzini G, Koeleman BPC, Sander T. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet 2012; 21:5359-72. [PMID: 22949513 DOI: 10.1093/hmg/dds373] [Citation(s) in RCA: 113] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Genetic generalized epilepsies (GGEs) have a lifetime prevalence of 0.3% and account for 20-30% of all epilepsies. Despite their high heritability of 80%, the genetic factors predisposing to GGEs remain elusive. To identify susceptibility variants shared across common GGE syndromes, we carried out a two-stage genome-wide association study (GWAS) including 3020 patients with GGEs and 3954 controls of European ancestry. To dissect out syndrome-related variants, we also explored two distinct GGE subgroups comprising 1434 patients with genetic absence epilepsies (GAEs) and 1134 patients with juvenile myoclonic epilepsy (JME). Joint Stage-1 and 2 analyses revealed genome-wide significant associations for GGEs at 2p16.1 (rs13026414, P(meta) = 2.5 × 10(-9), OR[T] = 0.81) and 17q21.32 (rs72823592, P(meta) = 9.3 × 10(-9), OR[A] = 0.77). The search for syndrome-related susceptibility alleles identified significant associations for GAEs at 2q22.3 (rs10496964, P(meta) = 9.1 × 10(-9), OR[T] = 0.68) and at 1q43 for JME (rs12059546, P(meta) = 4.1 × 10(-8), OR[G] = 1.42). Suggestive evidence for an association with GGEs was found in the region 2q24.3 (rs11890028, P(meta) = 4.0 × 10(-6)) nearby the SCN1A gene, which is currently the gene with the largest number of known epilepsy-related mutations. The associated regions harbor high-ranking candidate genes: CHRM3 at 1q43, VRK2 at 2p16.1, ZEB2 at 2q22.3, SCN1A at 2q24.3 and PNPO at 17q21.32. Further replication efforts are necessary to elucidate whether these positional candidate genes contribute to the heritability of the common GGE syndromes.
Collapse
Affiliation(s)
-
- Institute for Medical Biometry, Informatic and Epidemiology, University of Bonn, Bonn, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, Völzke H, Beuschlein F, Seissler J, Rettig R, Felix SB, Biffar R, Döring A, Meisinger C, Peters A, Wichmann HE, Nauck M, Wallaschofski H, Reincke M. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol 2012; 167:7-15. [PMID: 22495491 DOI: 10.1530/eje-11-1013] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE The prevalence of primary aldosteronism in unselected hypertensive patients is currently unknown. We investigated the frequency of positive screening results for primary aldosteronism based on the aldosterone-to-renin ratio (ARR) in hypertensive subjects aged 30-79 years from two German epidemiological studies. We further examined the frequency of positive screening results in subjects with resistant hypertension or stage III hypertension and assessed possible disparities between untreated and treated hypertensive subjects. METHODS Data were obtained from the first follow-ups of the population-based study of health in Pomerania (SHIP; n=1392) and the cooperative health research in the region of Augsburg (KORA; n=1052). Study-specific reference ranges for plasma aldosterone concentration (PAC), plasma renin concentration (PRC) and the ARR were applied. Confirmation tests for primary aldosteronism were not performed in these epidemiological studies.Three definitions for a positive screening for primary aldosteronism were applied: A) increased ARR; B) increased ARR and decreased PRC; and C) increased ARR and increased PAC and decreased PRC. RESULTS The frequency of positive screening results was 7.0, 3.8 and 0.2% according to definitions A-C respectively. In the subgroups of subjects with resistant hypertension (11.9, 5.5 and 0.9%) or stage III hypertension (18.3, 14.0 and 1.1%), these frequencies were markedly higher than those in the general hypertensive population. There was no difference in the frequency of positive screening results between the treated and untreated hypertensive subjects. CONCLUSIONS A maximum of 7.0% of the hypertensive population in Germany shows a positive screening result for primary aldosteronism. Thus, primary aldosteronism may be less frequent than previously expected based on data from referred hypertensive patients.
Collapse
Affiliation(s)
- A Hannemann
- Institute of Clinical Chemistry and Laboratory Medicine, Ernst-Moritz-Arndt-University Greifswald, Ferdinand-Sauerbruch-Strasse, D-17475 Greifswald, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Hobbs A, Starkbaum J, Gottweis U, Wichmann HE, Gottweis H. The privacy-reciprocity connection in biobanking: comparing German with UK strategies. Public Health Genomics 2012; 15:272-84. [PMID: 22722691 DOI: 10.1159/000336671] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
In recent years, the adequacy of the 'gift' model of research participation has been increasingly questioned. This study used focus groups to explore how potential and actual participants of biobanks in the UK and Germany negotiate the relationship between concerns over privacy protection, reciprocity and benefit sharing. In Germany, 15 focus groups (n = 151) were conducted: 11 general public groups (n = 116) and 4 with former cohort study participants including the KORA and the Popgen cohort study (n = 35). In the UK, 9 focus groups (n = 61) were conducted: 4 general public groups (n = 33) and 5 with UK Biobank and European Huntington's Disease (Euro-HD) Registry biorepository participants (n = 28). Forms of reciprocity were found to partially mitigate potential and actual biobank participants' concerns over personal privacy risks and future unintended consequences of biobank in both Germany and the UK. Specifically, notions of individual reciprocity were at the forefront in the context of personal disadvantages to participation, while communal reciprocity was prominent when potential and actual participants were discussing the uncertainty of the long-term nature of biobanking. The research indicates that reciprocity can be viewed as a mode to deal with individuals' concerns about participating in a biobank, both by acting as a return 'favor' or 'gift,' and through establishing an ongoing relationship between participants, researchers and society. It is suggested that future biobanking projects will need to flexibly combine individual and communal forms of reciprocity if they are to recruit and maintain sufficient numbers of participants.
Collapse
Affiliation(s)
- A Hobbs
- Science and Technology Studies Unit, Department of Sociology, University of York, York, UK
| | | | | | | | | |
Collapse
|
45
|
Schulz H, Albrecht E, Behr J, Huber RM, Nowak D, Klopp N, Codd V, Saman N, Gieger C, Heinrich J, Wichmann HE, Peters A, Jörres RA, Karrasch S. Are spirometric lung function indices associated with telomere length of circulating leukocytes? Pneumologie 2012. [DOI: 10.1055/s-0032-1315556] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
Schulz H, Albrecht E, Karrasch S, Behr J, Huber RM, Nowak D, Klopp N, Codd V, Samani N, Gieger C, Heinrich J, Wichmann HE, Peters A, Jörres RA. Gibt es eine Assoziation zwischen spirometrischen Kennwerten und der Telomerenlänge in Leukozyten des peripheren Bluts? Pneumologie 2012. [DOI: 10.1055/s-0032-1302538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Dieudé P, Bouaziz M, Guedj M, Riemekasten G, Airò P, Müller M, Cusi D, Matucci-Cerinic M, Melchers I, Koenig W, Salvi E, Wichmann HE, Cuomo G, Hachulla E, Diot E, Hunzelmann N, Caramaschi P, Mouthon L, Riccieri V, Distler J, Tarner I, Avouac J, Meyer O, Kahan A, Chiocchia G, Boileau C, Allanore Y. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. ACTA ACUST UNITED AC 2012; 63:3979-87. [PMID: 21898345 DOI: 10.1002/art.30640] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE Several autoimmune disorders, including systemic sclerosis (SSc), are characterized by a strong sex bias. To date, it is not known whether genes on the sex chromosomes influence SSc susceptibility. Recently, an IRAK1 haplotype that contains the 196Phe functional variant (rs1059702), located on Xq28, was found to confer susceptibility to systemic lupus erythematosus (SLE). This study was undertaken to test for an association between SSc and the IRAK1 SLE risk haplotype. METHODS We tested for an association with the IRAK1 SLE risk haplotype in a discovery set of 849 SSc patients and 625 controls. IRAK1 rs1059702 was further genotyped in a replication set, which included Caucasian women from Italy (493 SSc patients and 509 controls) and Germany (466 SSc patients and 1,083 controls). RESULTS An association between the IRAK1 haplotype and SSc was detected in the discovery set. In both the discovery and replication sets, the rs1059702 TT genotype was found to be associated with specific SSc subsets, highlighting a potential contribution to disease severity. A meta-analysis provided evidence of an association of both the T allele and TT genotype with the overall disease, with an odds ratio (OR) of 1.20 and 95% confidence interval (95% CI) of 1.06-1.35 for the T allele (P = 0.003) and an OR of 1.49 and 95% CI of 1.06-2.10 for the TT genotype (P = 0.023). However, the most notable associations were observed with the diffuse cutaneous, anti-topoisomerase I antibody positive, and SSc-related fibrosing alveolitis subsets (OR 2.35 [95% CI 1.51-3.66], P = 1.56 × 10(-4), OR 2.84 [95% CI 1.87-4.32], P = 1.07 × 10(-6), and OR 2.09 [95% CI 1.35-3.24], P = 9.05 × 10(-4), respectively). CONCLUSION Our study provides the first evidence of an association between IRAK1 and SSc, demonstrating that a sex chromosome gene directly influences SSc susceptibility and its phenotypic heterogeneity.
Collapse
Affiliation(s)
- P Dieudé
- Paris Diderot University, AP-HP, INSERM U699, Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Müller TD, Greene BH, Bellodi L, Cavallini MC, Cellini E, Di Bella D, Ehrlich S, Erzegovesi S, Estivill X, Fernández-Aranda F, Fichter M, Fleischhaker C, Scherag S, Gratacòs M, Grallert H, Herpertz-Dahlmann B, Herzog W, Illig T, Lehmkuhl U, Nacmias B, Ribasés M, Ricca V, Schäfer H, Scherag A, Sorbi S, Wichmann HE, Hebebrand J, Hinney A. Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts 2012; 5:408-19. [PMID: 22797368 DOI: 10.1159/000340057] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2011] [Accepted: 12/19/2011] [Indexed: 11/19/2022] Open
Abstract
OBJECTIVE The common single nucleotide polymorphism (SNP) rs9939609 in the fat mass and obesity-associated gene (FTO) is associated with obesity. As genetic variants associated with weight regulation might also be implicated in the etiology of eating disorders, we evaluated whether SNP rs9939609 is associated with bulimia nervosa (BN) and anorexia nervosa (AN). METHODS Association of rs9939609 with BN and AN was assessed in 689 patients with AN, 477 patients with BN, 984 healthy non-population-based controls, and 3,951 population-based controls (KORA-S4). Based on the familial and premorbid occurrence of obesity in patients with BN, we hypothesized an association of the obesity risk A-allele with BN. RESULTS In accordance with our hypothesis, we observed evidence for association of the rs9939609 A-allele with BN when compared to the non-population-based controls (unadjusted odds ratio (OR) = 1.142, one-sided 95% confidence interval (CI) 1.001-∞; one-sided p = 0.049) and a trend in the population-based controls (OR = 1.124, one-sided 95% CI 0.932-∞; one-sided p = 0.056). Interestingly, compared to both control groups, we further detected a nominal association of the rs9939609 A-allele to AN (OR = 1.181, 95% CI 1.027-1.359, two-sided p = 0.020 or OR = 1.673, 95% CI 1.101-2.541, two-sided p = 0.015,). CONCLUSION Our data suggest that the obesity-predisposing FTO allele might be relevant in both AN and BN.
Collapse
Affiliation(s)
- Timo D Müller
- Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg-Essen, Essen, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I, Wichmann HE, Merletti F, Richiardi L, Simonato L, Fortes C, Siemiatycki J, Parent ME, Consonni D, Landi MT, Caporaso N, Zaridze D, Cassidy A, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Stücker I, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Rudin CM, Brennan P, Boffetta P, Straif K, Brüning T. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 2011; 131:1210-9. [PMID: 22052329 DOI: 10.1002/ijc.27339] [Citation(s) in RCA: 332] [Impact Index Per Article: 25.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2011] [Accepted: 08/17/2011] [Indexed: 12/12/2022]
Abstract
Lung cancer is mainly caused by smoking, but the quantitative relations between smoking and histologic subtypes of lung cancer remain inconclusive. By using one of the largest lung cancer datasets ever assembled, we explored the impact of smoking on risks of the major cell types of lung cancer. This pooled analysis included 13,169 cases and 16,010 controls from Europe and Canada. Studies with population controls comprised 66.5% of the subjects. Adenocarcinoma (AdCa) was the most prevalent subtype in never smokers and in women. Squamous cell carcinoma (SqCC) predominated in male smokers. Age-adjusted odds ratios (ORs) were estimated with logistic regression. ORs were elevated for all metrics of exposure to cigarette smoke and were higher for SqCC and small cell lung cancer (SCLC) than for AdCa. Current male smokers with an average daily dose of >30 cigarettes had ORs of 103.5 (95% confidence interval (CI): 74.8-143.2) for SqCC, 111.3 (95% CI: 69.8-177.5) for SCLC and 21.9 (95% CI: 16.6-29.0) for AdCa. In women, the corresponding ORs were 62.7 (95% CI: 31.5-124.6), 108.6 (95% CI: 50.7-232.8) and 16.8 (95% CI: 9.2-30.6), respectively. Although ORs started to decline soon after quitting, they did not fully return to the baseline risk of never smokers even 35 years after cessation. The major result that smoking exerted a steeper risk gradient on SqCC and SCLC than on AdCa is in line with previous population data and biological understanding of lung cancer development.
Collapse
Affiliation(s)
- Beate Pesch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of Ruhr Universität Bochum (IPA), Bochum, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Filipiak-Pittroff B, Schnopp C, Berdel D, Naumann A, Sedlmeier S, Onken A, Rodriguez E, Fölster-Holst R, Baurecht H, Ollert M, Ring J, Cramer C, von Berg A, Bauer CP, Herbarth O, Lehmann I, Schaaf B, Koletzko S, Wichmann HE, Heinrich J, Weidinger S. Predictive value of food sensitization and filaggrin mutations in children with eczema. J Allergy Clin Immunol 2011; 128:1235-1241.e5. [PMID: 22030464 DOI: 10.1016/j.jaci.2011.09.014] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2011] [Revised: 09/13/2011] [Accepted: 09/13/2011] [Indexed: 11/26/2022]
Abstract
BACKGROUND It was reported that in infants with eczema and food sensitization, the presence of a filaggrin (FLG) null mutation predicts future asthma with a specificity and positive predictive value of 100%. OBJECTIVES We sought to evaluate the predictive value of food sensitization and food allergy, FLG haploinsufficiency, and their combination in infants with early-onset eczema for persistent eczema and childhood asthma. METHODS The German Infant Nutritional Intervention (GINI) and Influence of Lifestyle-related Factors on the Immune System and the Development of Allergies in Childhood (LISA) birth cohorts, as well as a collection of 65 cases of early-onset eczema with and without food allergy were investigated. RESULTS The risk for asthma was significantly increased by food sensitization (positive diagnostic likelihood ratios [PLRs] of 1.9 [95% CI, 1.1-3.4] in the GINI cohort and 5.5 [95% CI, 2.8-10.8] in the LISA cohort) and the presence of an FLG mutation (PLRs of 2.9 [95% CI, 1.2-6.6] in the GINI cohort and 2.8 [95% CI, 1.0-7.9] in the LISA cohort) with a rather high specificity (79.1% and 92.9% in the GINI cohort and 89.0% and 91.7% in the LISA cohort, respectively) but low sensitivity (40.0% and 39.3% in the GINI cohort and 31.6% and 23.5% in the LISA cohort, respectively). Likewise, the risk for persistent eczema was increased. In the clinical cases neither food allergy nor FLG mutations had a significant effect. The combination of both parameters did not improve prediction and reached positive predictive values of 52.3% (GINI cohort), 66.9% (LISA cohort), and 30.6% (clinical cases), assuming an asthma prevalence in children with early eczema of 30%. CONCLUSION Early food sensitization and the presence of an FLG mutation in infants with early eczema increase the risk for later asthma, but the combination of the 2 factors does not represent a clinically useful approach to reliably identify children at risk.
Collapse
Affiliation(s)
- Birgit Filipiak-Pittroff
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|